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 ABSTRACT 
Neurons can adjust their ionic currents to maintain a stable output. The homeostatic 
mechanisms that produce compensatory changes in ionic currents operate over multiple time 
scales. The rapid mechanisms that act over minutes are mostly unknown. We have been 
characterizing a fast homeostatic mechanism that stabilizes activity phase in the rhythmically 
active lateral pyloric neuron (LP) of the crustacean stomatogastric ganglion. LP activity phase is 
invariant. It is determined, in part, by the balance between the hyperpolarization-activated 
current (Ih) and the transient potassium current (IA). When LP IA is experimentally decreased, 
activity phase is initially disrupted, but then it recovers over minutes. This is because the 
decrease in IA modifies LP activity, which in turn alters cytosolic Ca2+ levels. Ca-dependent 
enzymes then mediate a reduction in LP Ih to restore the balance between the two conductances. 
We have been studying the molecular mechanisms that correlate LP IA and Ih in an activity-
dependent fashion. We have found that neuronal activity adjusts the level of ion channel post-
translational modification by Small Ubiquitin-like Modifier (SUMO), a peptide which when 
conjugated to target proteins alters their protein-protein interactions. Using a heterologous 
expression system, we showed that enhancing SUMOylation of HCN or Kv4 ion channels that 
mediate Ih and IA, respectively, produced opposite effects on the amplitudes of Ih and IA. We also 
demonstrated that a given change in activity produced the opposite effect on SUMOylation 
levels associated with each current. Thus, activity-dependent regulation of ion channel 
SUMOylation specified a positive correlation between the two currents. We have also 
demonstrated that activity-dependent regulation of ion channel SUMOylation is conditional; it 
only occurs in the presence of the appropriate modulatory tone. We showed this is because 
modulators, like dopamine, specify the targets of the SUMOylation machinery. In sum, we have 
discovered a novel mechanism that acts over minutes to correlate ionic conductances and thereby 
stabilize neuronal output. 
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1 
1 INTRODUCTION  
Rhythmically active networks drive such functions as walking, swallowing, breathing, 
and swimming. These types of networks require that the precise timing of component neuron 
firing remain stable while still being flexible enough to respond to external stimuli. Thus, a 
mechanism is needed to stabilize neuronal excitability and maintain activity within a specific 
range. In the rhythmically active pyloric network of the spiny lobster, the timing of network 
neuron firing (phase) is maintained within a narrow range across individual animals (Bucher, 
Prinz et al. 2005, Goaillard, Taylor et al. 2009). Maintenance of pyloric neuron phase has been 
attributed to multiple cellular and synaptic parameters including the correlation of specific ionic 
conductances (Soofi, Archila et al. 2012, Zhao and Golowasch 2012). Researchers have 
described a long-term mechanism that acts through transcription and translation to maintain these 
correlations. However, we have published evidence that alterations in phase can be restored over 
minutes in the presence of tonic Dopamine (DA) (Krenz, Rodgers et al. 2015), indicating that a 
fast activity-dependent mechanism also exists to maintain phase. This dissertation will 
investigate a novel role for Small Ubiquitin-like Modifier (SUMO) in the rapid coregulation of 
the transient potassium current (IA) and the hyperpolarization-activated current (Ih). We will also 
begin to characterize the involvement of tonic DA in the SUMO-mediated activity-dependent 
regulation of ionic conductances. 
1.1 Stomatogastric Nervous System 
The crustacean Stomatogastric Ganglion (STG) is a component of the Stomatogastric 
Nervous System (STNS), a well-characterized central pattern generator that drives the rhythmic 
contraction of the gut and foregut of the spiny lobster. The STG has long been an ideal model 
system for studying motor pattern generation and the effects of neuromodulation on a neural 
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circuit. Modulatory input is sent to the STG via descending inputs through the stn (Fig 1.2A; 
CoG), as well as being present in the hemolymph that is continuously bathing the ganglion 
(Oginsky, Rodgers et al. 2010, Hedrich, Diehl et al. 2011). Our work will focus on the pyloric 
circuit of the STG, a 14-neuron recurrent inhibitory circuit that drives the rhythmic contraction 
of the foregut (Fig 1.2C). The pyloric circuit produces a triphasic rhythm, that can be observed in 
vivo and in situ, through the patterned bursting of six different cell types. Each neuron fires in a 
particular phase relative to the other neurons. The firing pattern is set by the electrically coupled 
pacemaker kernel, composed of the anterior burster (AB) and the two pyloric dilator (PD) 
neurons, which simultaneously inhibit follower neurons (LP, PY, IC, and VD) (Fig 1.2C) 
(Marder and Bucher 2007). Through post-inhibitory rebound (PIR) the follower neurons 
repolarize and fire a burst of action potentials. The varying rates of PIR together with the 
synaptic architecture determine the order and timing of each follower neuron’s burst. The lateral 
pyloric (LP) and inferior cardiac (IC) neurons recover first following pacemaker inhibition. Next 
the pyloric (PY) and ventricular dilator (VD) neurons fire to complete the triphasic cycle 
(Fig1.2B).  
The LP neuron will be the primary focus of our research. LP functions in the circuit to 
slow increasing cycle frequencies. It sets an upper limit on cycle frequency by inhibiting PD. 
The timing of LP inhibition is critical because it maintains the narrow range of frequencies the 
network experiences. Without LP feedback on the pacemaker, frequencies could increase outside 
of that range and disrupt network activity (Weaver and Hooper 2003). The timing of LP 
inhibition is determined by its PIR (Johnson, Brown et al. 2011). The ratio of two opposing ionic 
conductances, IA and Ih, regulates the rate of PIR (Harris-Warrick, Coniglio et al. 1995). 
Hyperpolarized potentials remove IA inactivation, and activate Ih, depolarizing the cell (He, Chen 
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et al. 2014). Upon depolarization IA is activated, producing an inward current that slows 
depolarization (Tierney and Harris-Warrick 1992, Birnbaum, Varga et al. 2004). In part, it is the 
balance between these two currents, one depolarizing the cell, the other slowing that 
depolarization, in part regulate the time at which the neuron fires its burst of action potentials.  
The distribution, function, and regulation of IA and Ih have been extensively studied in the 
STG. In the pyloric network, IA plays an important role in determining neuron firing phase, cycle 
frequency, and spike frequency (Tierney and Harris-Warrick 1992, Harris-Warrick, Coniglio et 
al. 1995). The shal channel that mediates IA undergoes extensive alternative splicing with the 
biophysical properties of the different spliceforms showing significant variability (Baro, Levini 
et al. 1997, Baro, Ayali et al. 2000, Baro, Quinones et al. 2001). Shal channels are primarily 
localized to the somatic membrane, primary neurites, and the neuropil of STG neurons (Baro, 
Ayali et al. 2000). Ih plays a critical role in neuronal excitability, rhythmic activity, and synaptic 
function (Robinson and Siegelbaum 2003, Goeritz, Ouyang et al. 2011, Kase and Imoto 2012). 
The Hyperpolarization-activated Cyclic Nucleotide-gated (HCN) channel that mediates Ih in the 
STG is also subject to alternative splicing, and the identified spliceforms show large variability 
in activation kinetic and voltage dependences (Ouyang, Goeritz et al. 2007). HCN channels 
primarily localize to the fine neural in the STG, in close proximity to synapses (Goeritz, Ouyang 
et al. 2011). Researchers have overexpressed shal in identified pyloric neurons and observed a 
corresponding increase in expression of Ih that prevented any significant changes in network 
activity (MacLean, Zhang et al. 2003, MacLean, Zhang et al. 2005). Interestingly, when the 
reciprocal experiment was performed, overexpressing Ih did not lead to a corresponding increase 
in IA expression (Zhang, Oliva et al. 2003). However, additional studies have also demonstrated 
correlated expression of IA and Ih and have underscored its importance in maintaining stable 
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network activity (Khorkova and Golowasch 2007, Hudson and Prinz 2010, Temporal, Desai et 
al. 2012, Zhao and Golowasch 2012, Golowasch 2014).  
Phase refers to the timing of network neuron firing relative to the other network 
components. We study LP-on phase, which refers to the timing of LP firing relative to the 
pacemaker, and is calculated by dividing the LP-on delay by the cycle period (Fig 1.2B; b÷a) 
(Rodgers, Fu et al. 2011). Despite there being several-fold variability in conductance levels and 
synaptic strengths across individuals, phase and the IA:Ih ratio are both highly conserved, 
underscoring their importance (Bucher, Prinz et al. 2005, Goaillard, Taylor et al. 2009). 
Maintaining IA:Ih requires a regulatory mechanism or homeostat (MacLean, Zhang et al. 2003, 
MacLean, Zhang et al. 2005), and recent evidence indicates that tonic DA modulation may be 
part of that mechanism (Rodgers, Fu et al. 2011, Krenz, Hooper et al. 2013, Krenz, Parker et al. 
2015). 
1.2 Dopamine  
DA is a neuromodulator that plays an essential role in many neurological processes such 
as motor control, reward, and motivation. Dysfunction of the dopaminergic system can result in a 
variety of conditions including Parkinson’s Disease, Schizophrenia, Restless Leg Syndrome, and 
Attention Deficit Disorder (ADHD)(Schultz 2007). DA is released from dopaminergic neurons 
through volume transmission in many model systems, including the STNS (Oginsky, Rodgers et 
al. 2010). As opposed to a classical synapse where receptors are located within the synaptic cleft, 
directly adjacent to where the neuromodulator is being released, DA releases far away from its 
receptor and diffuses to reach them or reach distant reuptake mechanisms (Schultz 2007). 
Tonically active DA neurons produce a constant presence of DA at nanomolar (nM) levels, 
referred to as tonic DA (Schultz 2007, Owesson-White, Roitman et al. 2012, Nirogi, Komarneni 
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et al. 2013). Upon stimulation, dopaminergic neurons will release DA in bursts. This produces a 
transient increase in DA concentration that can reach micromolar (μM) to millimolar (mM) 
levels near the dopaminergic neuron at the time of release, and is referred to as phasic DA 
(Justice 1993, Goto, Otani et al. 2007, Rice, Patel et al. 2011). DA receptors can be present in 
either a high or low-affinity states. Tonic DA will activate high-affinity receptors, while phasic 
DA will activate low-affinity DA receptors, producing different responses in the target neuron. 
Tonic DA plays an enabling role and is known to enable motor, cognitive, and motivational 
processes (Bilder, Volavka et al. 2004, Krenz, Hooper et al. 2013, Krenz, Rodgers et al. 2015). 
On the other hand, phasic DA modifies these processes and many others (Schultz 2007, 
Bromberg-Martin, Matsumoto et al. 2010, Lisman, Grace et al. 2011). DA activates either type-1 
or type-2 receptors (D1R and D2R respectively). Both receptors couple with G proteins and 
activation of these receptors have opposing effects. D1R’s, acting through Gs increase adenylyl 
cyclase activity while D2R’s acting through Gi/o decrease it (Clark and Baro 2006, Clark, Khan 
et al. 2008). LP exclusively expresses D1Rs, therefore, the work presented here will focus on the 
canonical D1R pathway. 
1.3 Dopamine in the STG 
In the STG, phasic and tonic DA can affect many aspects of the network including 
rhythmic activity, the firing properties of specific neurons, synaptic strengths, and ionic 
conductances. Bath applying phasic DA to the STG alters the firing properties of each pyloric 
neuron differently (Harris-Warrick, Johnson et al. 1998). Since these early findings, additional 
studies have characterized the specific effects of DA on network output, synaptic strengths, and 
specific ionic conductances. In a study that examined the effects of phasic DA on the cycle 
frequencies of isolated pyloric neurons and the complete pyloric network, they found that phasic 
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concentrations of DA slightly decreased the cycle frequency of the pyloric rhythm (Ayali and 
Harris-Warrick 1999). This overall decrease in cycle frequency closely resembled the DA 
modulated decrease in the isolated AB-2xPD pacemaker kernel, resulting from the combination 
of an increase in AB frequency paired with a decrease in the frequencies of both PD neurons. 
Researchers have also characterized the pre- and postsynaptic effects of DA modulation at many 
of the pyloric synapses. As was mentioned before the synapse between LP and PD is particularly 
important because LP directly inhibits the pacemaker and can function to slow the network 
rhythm. DA modulation enhances LP pre-synaptic transmitter release through an increase in 
calcium levels at the presynaptic terminals and decreases the PD post-synaptic responsiveness to 
the transmitter (Johnson, Peck et al. 1995, Cleland and Selverston 1997, Johnson and Harris-
Warrick 1997, Johnson, Kloppenburg et al. 2003, Kloppenburg, Zipfel et al. 2007, Johnson, 
Brown et al. 2011). The net outcome of these opposing effects is an overall enhancement of the 
inhibitory LP/PD synapse. Common among many pyloric neurons is DA modulation of IA and Ih, 
although the directionality of this modulation can differ between neuron types. For instance, 
phasic concentrations of DA reduce IA in the AB, PY, and IC neurons (Peck, Nakanishi et al. 
2001), while it increases IA in the PD neuron (Kloppenburg, Levini et al. 1999). Phasic DA 
significantly shifted the voltage of activation in the depolarized direction without changing Gmax 
in LP, AB, PY, and VD neurons, with no effect on PD and IC Ih (Harris-Warrick, Coniglio et al. 
1995, Peck, Gaier et al. 2006).  
Our work focuses on the mechanisms that regulate LP neuron activity, and bath 
application of phasic µM DA decreases LP IA, disrupting the LP IA:Ih ratio and producing an 
advance in LP-on phase (Rodgers, Fu et al. 2011). The phase advance is accompanied by an 
increase in network cycle frequency and a decrease in LP burst duration. With persistent 
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exposure to phasic µM levels of DA, LP phase recovers while cycle frequency and burst duration 
remained altered (Rodgers, Fu et al. 2011, Krenz, Hooper et al. 2013). Additional studies have 
begun to describe both long and short-term mechanisms that regulate IA and Ih and the role of 
tonic DA in this regulation.  
To date, studies examining the correlation between Ih and IA have focused long-term 
mechanisms that coregulate the two conductances through transcription and translation (Schulz, 
Goaillard et al. 2007, Temporal, Desai et al. 2012). We have demonstrated that tonic DA can 
regulate both LP IA and Ih over the long-term through transcription and translation. Tonic DA 
persistently increases LP IA Gmax through a translation-dependent mechanism (Rodgers, Krenz et 
al. 2011, Rodgers, Krenz et al. 2013). We also showed that when LP-on phase is advanced in a 
manner that is thought to be mediated by an increase in IA, phase can recover in the presence of 
tonic DA over the course of an hour (Rodgers, Fu et al. 2011). When changes in LP Ih were 
prevented phase recovery was no longer observed in the presence of tonic DA (Rodgers, Fu et al. 
2011, Krenz, Hooper et al. 2013). These findings indicate that tonic DA may stabilize network 
activity through translation-dependent long-term regulation of LP IA and Ih, likely to maintain the 
previously described IA:Ih.  
Although a majority of the literature examining the coregulation of ionic conductances 
describes a long-term mechanism acting over hours, logic would dictate that a short-term 
mechanism may also exist to restore conductance correlations and maintain stable network 
activity rapidly. Our recent findings have begun to describe an activity-dependent mechanism 
that can regulate ionic currents over minutes to restore LP-on phase. Rapid recovery of LP-on 
phase was demonstrated by pharmacologically decreasing IA, advancing LP-on phase after only 
1min (Krenz, Rodgers et al. 2015). LP-on phase recovered after only 20 mins, in the presence but 
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not the absence of tonic DA. Additional experiments that prevented changes in LP Ih with Cs 
showed that phase was no longer recovered in the presence of tonic (Krenz, Hooper et al. 2013, 
Krenz, Rodgers et al. 2015). We found that in fact tonic DA LP Ih Gmax to be bidirectionally 
regulated by changes in duty cycle.  
In the presence but not the absence of tonic DA (5nM), bidirectional changes in LP duty 
cycle (LP burst duration ÷ cycle period) produce corresponding bidirectional changes in LP Ih 
Gmax (Krenz, Rodgers et al. 2015). In these experiments, the STG was superfused with saline 
containing or lacking (control) 5nM DA and slow wave and spike activity were blocked with 
TTX. LP activity, measured before TTX application, was used to construct a voltage step 
protocol to mimic the slow wave oscillations of LP. This voltage step protocol was then used to 
increase or decrease LP duty cycle and Ih was measured before and 10min after applying the 
voltage protocol. When the change in LP Ih Gmax (Ih Gmax after voltage protocol ÷ LP Ih Gmax 
before voltage protocol) was plotted against the change in LP duty cycle, we observed that LP Ih 
Gmax changed bidirectionally with changes in duty cycle (Krenz, Rodgers et al. 2015). Note that 
activity-dependent changes in LP Ih were only observed in the presence of tonic DA and that in 
the absence of DA there is no change in LP Ih Gmax regardless of activity. 
These experiments were followed by experiments that would begin to uncover the 
mechanism mediating LP Ih Gmax activity-dependent regulation (Krenz, Rodgers et al. 2015). We 
found that tonic DA acting through D1Rs activates PKA which has two simultaneous effects; 1- 
PKA produces an activity-independent increase in LP Ih Gmax, 2 – PKA permits calcineurin to 
decrease LP Ih Gmax in an activity-dependent manner (Krenz, Rodgers et al. 2015). The specific 
mechanisms that mediate these processes remain uncharacterized. The work presented here will 
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examine SUMO mediated activity-dependent coregulation of LP Ih and IA and the role of tonic 
DA in selecting the ionic conductance target of SUMOylation. 
1.4 SUMOylation mediates activity-dependent regulation of ion channels 
SUMO is a small peptide that is post-translationally added to target proteins, altering the 
properties of the modified protein in diverse ways. SUMOylation was first described over 20 
years ago for its role in regulating the cell cycle and was thought to be restricted to the nucleus 
(Matunis, Coutavas et al. 1996, Mahajan, Delphin et al. 1997). Since then SUMO substrates have 
been identified throughout the cell and have been shown to regulate a wide variety of processes 
including DNA repair, transcription, protein trafficking, cell migration (Hay 2005). Recent 
studies have implicated SUMOylation in the regulation of neuronal proteins with functional 
consequences that include the regulation of synaptic plasticity, and altering the biophysical 
properties and trafficking of ion channels (Flotho and Melchior 2013).  
There are four SUMO homologs in mammals (SUMO1-4). SUMO2 and 3 share ~97% 
homology and are often referred to as SUMO2/3 because they are not readily distinguishable by 
commercially available antibodies. Despite SUMO1 sharing only ~50% sequence identity with 
SUMO2/3 there is significant overlap in target proteins between SUMO1-3. The distribution and 
function of SUMO4 remains widely uncharacterized (Henley, Craig et al. 2014). SUMO is 
reversibly conjugated to the lysine residue of a target protein through an enzymatic cascade that 
closely resembles that of ubiquitin. Precursor SUMO requires proteolytic processing by a 
member of the sentrin protease (SENP) family to exposed the C-terminal diglycine motif before 
SUMO can be conjugated to a target protein. Mature SUMO is then activated through the 
formation of a thioester bond with the E1 SUMO-activating enzyme (SAE1/SAE2) (Fig 1.1). 
SUMO is then transferred to the single E2 SUMO-conjugating enzyme (Ubc9), which catalyzes 
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the formation of an isopeptide bond between the C-terminal diglycine of SUMO and the lysine 
of a target protein (Fig1.1). In some cases, SUMO conjugation by Ubc9 is facilitated by the 
presence of an E3 SUMO-ligase (Flotho and Melchior 2013). In most, but not all cases, 
SUMOylation occurs at a SUMO consensus sequence, ΨKXE (Ψ is a large hydrophobic residue 
and X can be any residue), that can be recognized by Ubc9. Conjugated SUMO can be cleaved 
from a target protein by SENP (Fig 1.1). Members of the SENP family of proteases differ in their 
affinity for different SUMO homologs as well as their ability to perform both hydrolase 
(maturing of precursor SUMO) and isopeptidase (deSUMOylation) functions (Mukhopadhyay 
and Dasso 2007, Nayak and Muller 2014).  
Once conjugated to a target protein, SUMO acts like a docking station, promoting 
interaction between the SUMOylated protein and other proteins that contain a SUMO Interacting 
Motif (SIM) domain (Hay 2013). By promoting protein-protein interactions, SUMO can 
coordinately regulate functionally related proteins. In neurons, SUMO is emerging as an 
important regulator of activity and modulator-dependent processes (Lu, Liu et al. 2009, Loriol, 
Khayachi et al. 2013, Loriol, Casse et al. 2014). Numerous reports have described SUMOylation 
as being necessary for the regulation of different ion channels, including Na+ channels 
(Dustrude, Wilson et al. 2013, Dustrude, Moutal et al. 2016, Plant, Marks et al. 2016), K+ 
channels (Benson, Li et al. 2007, Dai, Kolic et al. 2009, Plant, Dowdell et al. 2011, Qi, Wang et 
al. 2014), and multiple glutamate receptors subunits (O'Brien, Kamboj et al. 1998, Konopacki, 
Jaafari et al. 2011, Chamberlain, Gonzalez-Gonzalez et al. 2012, Jaafari, Konopacki et al. 2013, 
Choi, Park et al. 2016). SUMO regulation can alter the biophysical properties or trafficking of 
ion channels. SUMO-mediated regulation of these channels plays an important role in neuronal 
excitability (Dustrude, Wilson et al. 2013, Qi, Wang et al. 2014, Dustrude, Moutal et al. 2016), 
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neuronal homeostasis (Craig, Jaafari et al. 2012), LTP (Jaafari, Konopacki et al. 2013, Nair, Patil 
et al. 2017), and LTD (Chamberlain, Gonzalez-Gonzalez et al. 2012, Luo, Ashikaga et al. 2013). 
SUMO has also been implicated in several neuronal disease states including seizures (Qi, Wang 
et al. 2014), Parkinson’s Disease (Eckermann 2013, Guerra de Souza, Prediger et al. 2016), 
Alzheimer’s Disease (Lee, Dale et al. 2014, Hoppe, Salbego et al. 2015), Huntington’s Disease 
(Ochaba, Monteys et al. 2016), and Down Syndrome (Schorova and Martin 2016). Ion channels 
can be regulated by SUMO through either direct modification of the channel or indirect 
modification of an interacting protein. For example, direct modification of the Nav1.2 channel 
results in a shift of voltage-dependence of activation to a more negative voltage (Plant, Marks et 
al. 2016). On the other hand, indirect SUMOylation of CRMP2 promotes CRMP2 interaction 
with NaV1.7 leading to an increase in channel externalization (Dustrude, Wilson et al. 2013, 
Dustrude, Moutal et al. 2016).  
1.5 Hypothesis 
The work presented here will seek to address the question, “what are the mechanisms that 
mediate fast activity-dependent regulation of correlated ionic conductances?” We hypothesize 
that SUMOylation mediates fast activity-dependent regulation of correlated ionic conductances. 
We test this hypothesis by first characterizing SUMO regulation of the HCN channel, that 
mediates Ih, using a heterologous expression system. Next, we will then look to see if SUMO 
mediates activity-dependent regulation of LP Ih Gmax in a similar manner to what was observed in 
the heterologous expression system. Finally, we will characterize activity-dependent regulation 
of LP IA and the role of SUMO in mediating activity-dependence. 
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Figure 1.1 SUMOylation 
The SUMO precursor protein is cleaved by SENP to expose its C-terminal diglycine motif (top). 
The mature SUMO is then conjugated to the SUMO activating enzyme (E1; SAE1/SAE2) 
through the formation of a thioester bond. SUMO is then passed to the SUMO conjugating 
enzyme (E2; Ubc9) which can then conjugate SUMO to a target protein through a process that 
may be facilitated by the presence of a SUMO ligase (E3). Once conjugated to a target protein 
SUMO acts as a docking site for proteins that possess a SIM domain, thus promoting protein-
protein interactions. SUMO can be deconjugated from a target protein by SENP 
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Figure 1.2 The Pyloric Network 
(A) The STNS is dissected and pinned into a dish. A Vaseline well is used to enclose the STG 
(blue box). Saline is continuously superfused through the well (blue arrows). The commissural 
ganglia (CoGs) contain DA neurons that project through the stn to the STG. Two of the 14 STG 
neurons are depicted here, PD (red) and LP (blue). PD and LP axons project through the dvn and 
lvn to reach their target muscles. (B) Extracellular recordings were taken from the lvn and pdn 
using pin electrodes. Intracellular recordings were also taken from LP and PD using 
micropipettes. LP on-phase is defined as LP on-delay (b) divided by cycle period (a). (C) The 
pyloric network: the 6 types of pyloric neurons (open circles) and their connectivity are 
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diagrammed. Closed circles represent inhibitory synapses. Red connections show inhibition from 
the pacemaker kernel, and resistor/diode connection between AB and PD depicts electrical 
coupling 
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2 DETAILED MATERIALS AND METHODS 
2.1 Hek cells 
2.1.1 Tissue Culture 
Cells were maintained in EMEM media (Corning; cat#10-009-CV) supplemented with 
10% Fetal Bovine Serum (Sigma Aldrich; cat#F6178) and 1% Penecillin Streptomycin (Sigma 
Aldrich; cat#P4333) at 37℃ and 5%CO2. For plates that needed to be split and passaged, media 
was aspirated and 1-2ml (for 100mm plates) of Trypsin-EDTA 0.25% (Gibco; cat#25200-056) 
was added to the plate and incubated for 2-3min, monitoring for cell detachment from the plate. 
Using a Pasteur pipette, any cells still attached to the plate were gently washed into one corner of 
the dish and the trypsin/cells suspension was transferred to of 15ml tube containing 5ml of 
complete media. Cells were gently pelleted at 2,000rpm for 2-3min. The liquid was aspirated 
from the cell pellet, the cells were gently resuspended in 1ml of complete media, an appropriate 
number of cells were dropped on a plate containing fresh media and gently swirled to distribute 
the cells evenly. Plates were returned to the 37℃ and 5%CO2 incubator. If a specific number of 
cells needed to be plated a hemocytometer was used to determine a cell count. Briefly, 
suspended cells were diluted in 500µl of complete media (1:25), 100µl of Trypan blue was 
added, gently mixed and incubated for 5min at room temperature. Cells were then pipetted into 
the hemocytometer and counted according to the instructions included with the hemocytometer. 
 
2.1.2 Cryopreservation 
For long-term storage of Hek cells, a confluent 100mm plate was trypsinized, cells were 
pelleted and resuspended in 1ml of complete media. Hek cell suspension was transferred to a 
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cryotube (Thermo Fisher; cat#368632) containing 75ul (7.5%) DMSO, inverted to mix and 
quickly placed in a styrofoam box inside of a -80℃ freezer. Once frozen, usually 24hr later, the 
cryotube was transferred to a dewar filled with liquid nitrogen.  
2.2 Calcium Phosphate Transfection 
Approximately 24hr before transfection, enough cells were seeded onto a 60mm culture 
dish to obtain ~60% confluence the next day (~1.9x106 cells). The next day, the media was 
changed 1hr before transfecting. For a 60mm plate, 25µg total of plasmid DNA (divided equally 
for co-transfections) was combined with TE Buffer (10mM Tris-HCl, 1mM EDTA) to obtain a 
total volume of 440µl. Next, 60µl of 2M CaCl2 was added drop wise to the DNA mixture, while 
gently flicking the tube. Next, 500µl of 2xHBS (275mM NaCl, 10mM KCl, 12mM dextrose, 
1.4mM Na2HPO4, 40mM HEPES, pH 7.05-7.10, sterile filtered) that had been slowly thawed at 
room temperature was added dropwise while mixing. DNA mixture was immediately added to 
the cells by carefully dropping it evenly over the plate and gently rocking the plate to distribute 
the DNA. Plates were returned to the incubator for 4hr, and then the media was changed. The 
transfection efficiency was checked 48hr later, and only plates with >80% efficiencies were used 
for western blotting experiments. 
2.3 GFP Immunoprecipitation 
2.3.1 Hek Cell Lysates 
To obtain a lysate, media was aspirated from a 100mm plate, and the plate was gently 
washed twice with cold PBS (137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4, pH 
7.4). Cells were lysed by adding 1ml of RIPA Buffer (50mM Tris-HCl pH7.4, 150mM NaCl, 
0.1% SDS, 0.5% Deoxycholate, 1% NP-40, 20mM EDTA, 20mM N-Ethylmaleimide, 1:100 
protease inhibitor cocktail) to the plate and incubating for 30min on ice, rocking the plate 
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occasionally. A cell scraper was used to scrape the contents of the plate into one corner where it 
could be collected and transferred to a microcentrifuge tube. Cell debris was pelleted at 
14,000rpm at 4℃ for 10min, and the supernatant (cell lysate) was transferred to a clean 
microcentrifuge tube. Protein concentration was determined by BCA Assay. Briefly, 25µl of 
lysate (diluted 1:1, 1:5, and 1:10) and Bovine Serum Albumin standards (0, 125, 250, 500, 750, 
1000, 1500, and 2000µg/ml) were added to the wells of a 96 well plate, noting of the order of the 
samples, 200µl of Reagent A:B (50:1) was added to each well, the plate was covered with plastic 
wrap and incubated at 37℃ for 30min. The absorbance was measured at 562nm on a plate reader 
and used with the standard concentrations to construct an xy-plot that was fit with a linear 
trendline. The equation for the trendline was then used to calculate the concentration of the lysate 
samples.  
2.3.2 Co-Immunoprecipitation 
Co-immunoprecipitation experiments of Hek cell lysates were performed using the Pierce 
Classic Magnetic IP & Co-IP Kit (Thermo Scientific cat# 88804). For GFP Co-IPs, 1mg of 
protein was combined with 2µl of an anti-GFP antibody (Abcam, cat# ab290) in a 
microcentrifuge tube with Pierce IP Lysis/Wash Buffer to a total volume of 500µl. 
Antibody/antigen complex was incubated together overnight at 4℃ with agitation. Magnetic 
beads were prepared by combining 25µl of the beads with 175µl of Pierce IP Lysis/Wash Buffer, 
collecting the beads on a magnetic stand, removing the supernatant, and repeating the wash with 
an additional 500µl of Pierce IP Lysis/Wash Buffer. The antigen/antibody complex was then 
added to the washed beads and incubated for 1hr at room temperature with agitation. The beads 
were then collected and washed twice with Pierce IP Lysis/Wash Buffer. To elute the 
immunoprecipitated product, 100µl of Elution Buffer was incubated with the beads for 10min at 
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room temperature, the beads were then collected, and the eluate was retained and neutralized 
with 10µl of Neutralization Buffer. 
2.4 Biotinylation 
Hek cells on 60mm plates were washed twice with 1ml of cold PBS-CM (PBS - 137mM 
NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4, pH 7.4 supplemented with 0.2mM CaCl2 
and 1.5mM MgCl2). Biotin was added to the plate (2ml of 1mg/ml in PBS-CM; Thermo Fisher; 
cat#21331) and incubated for 30min at 4℃. Cells were washed twice with ice cold PBS-CM, and 
then 2ml of Quench Buffer (PBS-CM, 1.5mM MgCl2, 0.2mM CaCl2, 100mM Glycine) was 
added to the plate and incubated for 15min at 4℃. Next, the cells were lysed in 500µl RIPA 
Buffer (1% NP40, 50mM Tris pH 7.4, 150mM NaCl, 0.1% SDS, 0.5% DOC, 2mM EDTA, 
protease inhibitor cocktail at 1:100) for 30min on ice, occasionally rocking the plate. Contents of 
the plate were scraped into one corner using a cell scraper (Thermo Fisher; cat#08100241), the 
lysate was transferred to 1.5ml microcentrifuge tube, and the cell debris was pelleted by 
centrifuging for 10min at 14,000rpm at 4℃. NeutrAvidin beads (Thermo Fisher; cat#29201) 
were prepared by adding 100µl of NeutrAvidin slurry to a spin column (Thermo Fisher; 
cat#69725) and washing three times with 500µl of PBS, centrifuging for 1min at 500xg between 
each wash. The bottom of the spin column was capped, and the cleared lysate was then incubated 
with the beads for 2hr at 4℃ with agitation. Columns were uncapped and centrifuged for 2min at 
1000xg; flow-through was retained as “intracellular fraction”. Beads were washed 3 times with 
500µl of Wash Buffer 1 (PBS supplemented with 1% NP40, and 0.1% SDS), 3 times with 500µl 
of Wash Buffer 2 (PBS supplemented with 0.1% NP40 and 0.5M NaCl), and then the tube was 
capped and 50µl of SDS Buffer (50mM Tris-HCl pH 6.8, 100mM DTT, 2% SDS, 0.1% 
Bromophenol blue, 10% glycerol) was added and incubated for 1hr at room temperature to elute 
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extracellular protein. Eluted protein (extracellular fraction) was centrifuged from the column into 
a clean tube at 1000xg for 2min. 
Intracellular and Extracellular fractions were run together on a western blot, and the blot 
was cut just above the 50kDa ladder marker. The portion of the blot containing proteins >50kDa 
was dually probed with anti-GFP (Santa Cruz Biotechnology; cat#sc-8334; rabbit polyclonal; 
1:2000) and anti-Na/K Pump (Abcam; cat#ab7671; mouse monoclonal; 1:3000) antibodies; with 
expected bands corresponding to GFP-HCN2 being ~150-250kDa and Na/K Pump being 
~100kDa. The portion of the blot containing proteins <50kDa was probed with an anti-Actin 
antibody (Santa-Cruz Biotechnology; cat#sc-1616-R; rabbit polyclonal; 1:2000) to confirm no 
intracellular contamination was present in extracellular samples. 
2.5 Whole Cell Patch Clamping of Hek Cells 
Poly-L-Lysine coated cover slips were prepared as follows: 20mm round glass coverslips 
(Fisher Scientific; cat#12-546-2) were sterilized with ethanol and placed in the wells of 8 well 
dishes (Thermo Fisher; cat#267062) to air-dry; enough 50µg/ml Poly-L-Lysine (Sigma Aldrich; 
cat#P1524; prepared at 1mg/ml and sterile filtered) was added to each well to cover the 
coverslips; coverslips were incubated with Poly-L-Lysine for 1hr at 37℃; Poly-L-Lysine was 
aspirated; coverslips were washed once with dH2O; allowed to air-dry and stored at 4℃. For 
whole-cell patch clamping, ~7x104 cells were seeded onto each coverslip 24-48hr before 
recording. Coverslips containing cells were perfused with extracellular saline (138mM NaCl, 
5.6mM KCl, 2.6mM CaCl2, 1.2mM MgCl2, 10mM HEPES, 10mM Glucose, pH 7.4). Fire 
polished patch pipettes (Sutter Instruments; cat#B120-69-15; 5-8MΩ) were filled with 
intracellular saline (10mM NaCl, 145mM KCl, 1mM MgCl2, 5mM HEPES, pH 7.2) and 
connected to the amplifier. To obtain a whole cell patch, a gentle negative pressure was used to 
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form a ≥1GΩ seal between the cell membrane and the opening of the micropipette. Suction was 
used to rupture the cell membrane and recordings were taken from cells that maintained a seal 
≥700 MΩ following rupture. PClamp software implemented voltage protocols that were used to 
elicit the current being studied. 
2.6 Tat-SUMO Peptide 
2.6.1 Tat-SUMO Construct 
Activated Panulirus interruptus SUMO (ending in diglycine) cDNA was obtained by 
PCR using specific primers that included EcoRI restriction sites on the 5’ and 3’ ends. Briefly, 
lobster cDNA was amplified using SUMO Forward (5’-TTTTGAATTCGATGTCCGAGGAAG 
CCAAGAA-3’) and SUMO Reverse Primers (5’-GGGGGAATTCTCACCCACCAGTTTGCTG 
CTGGAACAC-3’) with the following cycling parameters: 1cycle – 95℃ for 1min; 35℃ cycles 
– 95℃ for 30sec, 61℃ for 1min, 68℃ for 1min; 1 cycle – 68℃ for 5min. The ~275bp PCR 
product was gel isolated, and both the SUMO cDNA and pcDNA3 Tat HA vector (a gift from 
Matija Peterlin (Cujec, Okamoto et al. 1997); Addgene plasmid #14654) were cut with EcoRI 
(1ug of DNA to 1U of enzyme). The exposed ends of the cut Tat-HA vector were 
dephosphorylated using Calf Intestine Phosphatase (CIP), then the SUMO cDNA and Tat-HA 
vector were ligated at a 1:1, insert to vector ratio. The ligation product was transformed into 
competent cells, and the presence of colonies containing Tat-SUMO was identified by PCR 
using Tat vector-specific primers (For: 5’-GGGGGAATTCTCACCCACCAGTTTGCTGCTGG 
AACAC-3’). DNA from colonies containing Tat-SUMO were sequenced to confirm proper 
orientation of the insert. 
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2.6.2 Tat-SUMO Peptide Synthesis 
To synthesize the Tat-SUMO peptide, the plasmid was transformed into BL21-
CodonPlus (DE3)-RIPL E. coli (Agilent; cat#230280) and plated on NYZ agar plates. A single 
isolated colony was grown overnight in 200ml of NYZ broth containing ampicillin (100µg/ml) at 
37◦C with agitation. The 200ml overnight culture was then added to 1L of broth containing 
500µM IPTG to induce expression of the peptide, and further incubated for 5hr. Cells were 
divided among 250ml autoclaved bottles and pelleted at 8,000rmp for 10min at 4◦C, and the 
pellet was washed with cold PBS (137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM 
KH2PO4, pH7.4). Pelleted cells were resuspended in 20ml of Buffer Z (8M Urea, 100mM NaCl, 
20mM HEPES, pH8), transferred to autoclaved 50ml centrifuge tubes and sonicated on ice using 
a 10sec “on” 30sec “off” protocol at 15% amplitude for a total of 10min. Sonicate was cleared by 
centrifuging at 12,000rpm for 10mins at 4◦C. The supernatant was transferred to a clean tube and 
the cleared sonicate was equilibrated with 10mM imidazole. Next, 10ml of Ni-NTA agarose 
resin (Qiagen; cat#1018244) was equilibrated with Buffer Z containing 10mM imidazole and 
then incubated with the sonicate at 4◦C for 1hr. The resin mixture was added to a 
chromatography column (Bio-Rad; cat#7372512) and washed with 100ml of Buffer Z with 
10mM imidazole. The peptide was eluted with incrementally increasing concentrations of 
imidazole (100, 250, 500mM, and 1M; 10ml each) and the buffer was exchanged for PBS with 
10% glycerol using PD-10 desalting columns (GE Healthcare; cat#17085101). Peptide 
concentration was determined by BCA assay (as described in 2.5.1). 
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3 CHAPTER 1: SUMOYLATION OF THE HYPERPOLARIZATION-ACTIVATED 
CYCLIC NUCLEOTIDE-GATED CHANNEL 2 INCREASES SURFACE 
EXPRESSION AND THE MAXIMAL CONDUCTANCE OF THE 
HYPERPOLARIZATION-ACTIVATED CURRENT 
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3.1 Abstract 
SUMO is a ~10kDa peptide that can be post-translationally added to a lysine (K) on a 
target protein to facilitate protein-protein interactions. Recent studies have found that 
SUMOylation can be regulated in an activity-dependent manner and that ion channel 
SUMOylation can alter the biophysical properties and surface expression of the channel. HCN 
channel surface expression can be regulated in an activity-dependent manner through unknown 
processes. We hypothesized that SUMOylation might influence the surface expression of HCN2 
channels. In this manuscript, we show that HCN2 channels are SUMOylated in the mouse brain. 
Baseline levels of SUMOylation were also observed for a GFP-tagged HCN2 channel stably 
expressed in Hek cells. Elevating GFP-HCN2 channel SUMOylation above baseline in Hek cells 
led to an increase in surface expression that augmented Ih, mediated by these channels. Increased 
SUMOylation did not alter Ih voltage-dependence or kinetics of activation. There are five 
predicted intracellular SUMOylation sites on HCN2. Site-directed mutagenesis indicated that 
more than one K on the GFP-HCN2 channel was SUMOylated. Enhancing SUMOylation at one 
of the five predicted sites, K669, led to the increase in surface expression and Ih Gmax. The role of 
SUMOylation at additional sites is currently unknown. The SUMOylation site at K669 is also 
conserved in HCN1 channels. Aberrant SUMOylation has been linked to neurological diseases 
that also display alterations in HCN1 and HCN2 channel expression, such as seizures and 
Parkinson’s Disease. This work is the first report that HCN channels can be SUMOylated and 
that this can regulate surface expression and Ih. 
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3.2 Introduction 
Post-translational modifications can rapidly regulate proteins. SUMOylation is one such 
modification that is essential for most organisms (Flotho and Melchior 2013). SUMO (a.k.a. 
Sentrin) is a ~100 amino acid peptide that is covalently added to a lysine (K) residue on a target 
protein. The addition involves several steps. First, the immature SUMO protein is cleaved by a 
SENP, exposing a C-terminal diglycine (Mukhopadhyay and Dasso 2007). The SUMO E1 
activating enzyme then transfers the mature SUMO peptide to the E2 conjugating enzyme, Ubc9, 
which will then add SUMO to the target protein (Desterro, Thomson et al. 1997). SUMO can 
also be deconjugated from a target protein by SENP (Hickey, Wilson et al. 2012). In mammals, 
SUMO is encoded by a family of four genes, termed SUMO1-4 (Flotho and Melchior 2013). 
SUMO2 and SUMO3 proteins are ~97% identical and are not readily distinguishable in most 
experiments. SUMO 1 and SUMO2/3 proteins share ~46% identity, and their sets of targets 
greatly overlap. SUMO4 cannot be cleaved into the mature form by Ubc9, and its function is 
unclear. 
 Modification by SUMO is subject to numerous forms of regulation. The 
availability of the SUMOylation site on a target protein can be regulated by the presence of other 
post-translational modifications. For example, phosphorylation near the SUMOylation site can 
either inhibit or enhance SUMOylation (Bossis and Melchior 2006, Konopacki, Jaafari et al. 
2011). SUMOylation can also be regulated by the availability of SUMO and/or SUMOylation 
enzymes (Loriol, Khayachi et al. 2013).  
 SUMOylation mediates protein-protein interactions (Makhnevych, Sydorskyy et 
al. 2009, Flotho and Melchior 2013). As such, SUMO can coordinately regulate many diverse 
cellular processes ranging from DNA repair in the nucleus to signal transduction at the plasma 
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membrane (Hickey, Wilson et al. 2012). The effects of SUMO are observed throughout the 
neuron (Henley, Craig et al. 2014). SUMOylation can influence neuronal transcription by 
controlling the stability of transcription factors; for example, BMAL1 ubiquitination and 
degradation is enhanced when it is SUMOylated (Lee, Lee et al. 2008). SUMO can also regulate 
synaptic release. SUMOylation of the synaptic vesicle protein, RIM1α, promotes its direct 
interaction with Cav2.1 channels, causing them to form clusters, which leads to rapid exocytosis 
of synaptic vesicles (Girach, Craig et al. 2013). In addition, SUMOylation plays a role in the 
trafficking of integral membrane proteins such as kainate receptors. SUMOylation of GluK2 is 
required for agonist-induced internalization of the kainate receptor, likely by facilitating its 
interaction with scaffolding and/or trafficking proteins (Konopacki, Jaafari et al. 2011, 
Chamberlain, Gonzalez-Gonzalez et al. 2012). However, the distinct interaction that leads to 
GluK2 internalization is still unknown. Voltage-gated ion channels are fundamental constituents 
of the neuronal membrane. Their trafficking is complex and highly regulated. The functions of 
SUMOylation in voltage-gated ion channel trafficking are largely unknown. We are interested in 
the role of SUMOylation in the regulated trafficking of Hyperpolarization-activated Cyclic 
Nucleotide gated (HCN) ion channels. 
HCN channels play a pivotal role in shaping neuronal excitability and synaptic 
integration by influencing several neuronal activity features including membrane potential, firing 
threshold, resonance frequency, temporal summation and synaptic strength (Hutcheon and 
Yarom 2000, Wahl-Schott and Biel 2009, Shah 2014). The mammalian HCN1-4 gene family 
encodes distinct channel isoforms (He, Chen et al. 2014). All isoforms are permeable to K+ and 
Na+, activate upon hyperpolarization, and mediate a slowly depolarizing current termed the 
hyperpolarization-activated current (Ih). Besides being activated at hyperpolarized potentials, 
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HCN channels can also be gated by the binding of cyclic nucleotides to the C-terminal CNBD 
found in all isoforms (Robinson and Siegelbaum 2003, He, Chen et al. 2014).   
HCN isoforms differ in their biophysical properties and modulation by cAMP. Under 
basal conditions, the CNBD inhibits hyperpolarization-gating to a different extent in each 
isoform due to its isoform-specific interactions with the core transmembrane domain and the C-
linker that connects the CNBD to the transmembrane domain (Wang, Chen et al. 2001). This 
variable inhibition results in isoform-specific steady-state activation curves. For example, the 
steady-state activation curve of HCN2 channels is 20mV more hyperpolarized compared with 
HCN1 channels. Binding of cAMP to the CNBD relieves its inhibition on hyperpolarization-
gating. Because of the isoform-specific interactions between the CNBD and the C-linker, the 
effect of cAMP binding will vary with the isoform (Wang, Chen et al. 2001). For example, 
binding of cAMP to the CNBD of HCN2 and HCN1 channels shifts their respective activation 
curves to more positive potentials, but HCN2 channels display a 17mV shift while HCN1 
channels display a 4mV shift. Maximal effects of cAMP binding are observed for HCN2 and 
HCN4 isoforms. The activation kinetics also varies between isoforms with HCN1 and HCN4 
having the fastest and slowest activation kinetics, respectively.  
In addition to their distinct biophysical properties and cAMP modulation, each of the four 
isoforms also displays a unique expression pattern in the nervous system (He, Chen et al. 2014). 
HCN1 is highly enriched in the neocortex, hippocampus, cerebellar cortex and brainstem. HCN2 
is widely expressed in most brain regions, while HCN3 has low expression levels in the nervous 
system. HCN4 expression mirrors HCN1 and is also selectively expressed in several thalamic 
nuclei and neuronal populations in the basal ganglia and habenular cortex. The formation of 
heteromeric channels further enhances the complexity of Ih function and modulation in vivo. 
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HCN channel surface expression throughout the nervous system can be adjusted over 
several time courses (Zha, Brewster et al. 2008, Shah 2014, Furst and D'Avanzo 2015, Smith, Al 
Otaibi et al. 2015, Brennan, Baram et al. 2016). Regulated SUMOylation could play a role in the 
trafficking of HCN channels. Since the trafficking of HCN2 channels has been fairly well 
studied (see Discussion), here we examine SUMOylation of HCN2 channels. 
3.3 Methods 
3.3.1 Drugs 
All drugs were obtained from Sigma-Aldrich with the exception of Tween 20 (Fisher 
Scientific). 
3.3.2 Mouse Brain Membrane Preparations 
Nondenaturing: A single mouse forebrain was homogenized on ice in homogenization 
buffer (5mM NaH2PO4 buffer, 0.32M sucrose) supplemented with protease inhibitor cocktail 
(1:100, Sigma cat. #P8340) and 20mM N-Ethylmaleimide (NEM) to prevent SUMO 
deconjugation (Suzuki, Ichiyama et al. 1999). Cell debris was pelleted at 5,000rpm for 10min at 
4°C, and the supernatant was retained and further centrifuged at 40,000rpm for 90min at 4°C to 
pellet membrane-bound proteins. The supernatant was removed and the pellet containing 
intracellular and extracellular membrane bound proteins was resuspended in 1ml of resuspension 
buffer (0.5% SDS, 5nM NaH2PO4, protease inhibitor cocktail at 1:100) followed by shaking at 
4°C for 1hr. Denaturing: Tissue homogenization and centrifugation were the same as for the 
nondenaturing preparation. The membrane pellet was resuspended in 100µl of denaturing buffer 
(2% SDS, 50mM Tris-HCl pH7.5, 5mM DTT) followed by shaking at 4°C for 1hr. The 
preparation was then diluted to 1ml total volume with dH2O and boiled for 10min. In all cases 
protein concentration was determined with a bicinchoninic acid assay (BCA Assay, Pierce BCA 
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Protein Assay Kit). Mouse brain membrane fractions were obtained from whole mouse forebrain 
tissue generously provided by Dr. Chun Jiang. All animal procedures were conducted in 
compliance with the regulation of the Institutional Animal Care and Use Committee of Georgia 
State University. 
3.3.3 Plasmids and Antibodies 
A previously described mouse GFP-HCN2 fusion plasmid (Santoro, Wainger et al. 2004) 
was generously provided by Dr. Bina Santoro’s Lab. Plasmids for transient transfection include 
the following: mCherry2-C1 was a gift from Michael Davidson (Addgene plasmid #54563), 
Ubc9 (Yasugi and Howley 1996) was a gift from Peter Howley (Addgene plasmid #14438), 
SENP1 (Cheng, Kang et al. 2007) was a gift from Edward Yeh (Addgene plasmid #17357), and 
SUMO2 (Kamitani, Nguyen et al. 1998) was a gift from Edward Yeh (Addgene plasmid 
#17360). Antibodies used are shown in Table 1, and the specificity of each antibody was verified 
as indicated in the table. 
3.3.4 Site Directed Mutagenesis 
PCR was used to create two site-directed mutations in the GFP-HCN2 fusion plasmid 
described above: K534R and K669R. The two sets of primers are listed in Table 2. PrimeStar 
GXL polymerase (Takara) was used along with the buffer, nucleotides, and instructions supplied 
by the manufacturer. Typically, 10ng of plasmid DNA served as the template in a 50μl reaction. 
The cycling conditions were: 1x 98°C,1min; 30x 98°C,30sec, 68°C, 7min; 1x 68°C, 5min. Upon 
completion, 20 units of DpnI (Clontech) were added to the reaction, which was incubated at 
37°C for 1-2hr to digest the template DNA. Afterward, 1-2μl of the reaction was added to a 50μl 
aliquot of subcloning grade competent XL1blue cells (Agilent) and incubated on ice for 30min. 
The cells were then heat-shocked at 42°C for 45sec. NZY broth (100μl) was added, and the cells 
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were incubated at 37°C for 20min to allow for expression of kanamycin resistance. Cells were 
then plated on NZY plates containing 30μg/ml kanamycin and incubated at 37°C overnight. 
Plasmid DNA from resultant colonies was isolated (Qiagen), the insert was sequenced in its 
entirety, and analyzed with Lasergene software (DNAstar) to ensure that only the intended 
mutation was generated. All sequencing was done by the Georgia State University Cell Protein 
and DNA Core Facilities. To create multiple mutations, a previously mutated GFP-HCN2 fusion 
plasmid was used as the template for a PCR with a different primer. 
3.3.5 Cell culture, Stable and Transient Transfections 
Hek-293 cells and all cell culture reagents were obtained from American Type Culture 
Collection (ATCC; Manassas, VA). Hek-293 cells were cultured at 37°C, and 5% CO2 in EMEM 
media supplemented with 10% fetal bovine serum and 1% Penicillin-Streptomycin. 
Transfections to produce stable lines: A cell line stably expressing a GFP-HCN2 fusion protein 
(Hek-HCN2) was generated by transfecting a 60mm plate of Hek-293 cells with the GFP-HCN2 
plasmid using Lipofectamine 2000 (Invitrogen) according to instructions provided by the 
manufacturer. After two days, transfected cells were trypsinized, resuspended and replated to 
60mm plates (5-20l of a 1ml cell resuspension per 60mm plate) and the selection agent, G418 
(Geneticin, Gibco, 500µg/ml), was added to the media. After 3-5 weeks, individual colonies 
were selected using cloning rings. Stable expression was checked by fluorescence and whole cell 
patch clamping for Ih. In all cases, a colony was selected only if GFP and Ih was observed in 
every cell; however, the intensity of GFP expression and Ih maximal conductance could vary 
between colonies from the same transfection by a factor of 10, presumably due to differences in 
the number of copies of plasmid integrated into the host cell genome. Stable cell lines expressing 
mutant versions of GFP-HCN2 were generated in a similar fashion. Transient transfections: In 
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our hands, Lipofectamine transfection efficiencies ranged from 5-25%. This was not adequate for 
transient transfection experiments, which required 80-100% transfection efficiency. Therefore, a 
high efficiency calcium phosphate transfection was employed for immunoprecipitation, 
biotinylation and patch clamping experiments using transient transfection to increase or decrease 
SUMOylation. Briefly, cells were plated at ~60% confluence on 100mm or 60mm cell culture 
dishes 24hr before transfection. The media was changed at least 1hr before transfection. For a 
single 100mm or 60mm dish, 25µg or 10µg of total plasmid DNA, respectively, was diluted in 
TE buffer (10mM Tris-HCl pH8, 1mM EDTA), 2M CaCl2 was added dropwise to the DNA 
followed by the addition of 2x HBS (275mM NaCl, 10mM KCl, 12mM Dextrose, 1.4mM 
Na2HPO4, 40mM HEPES, pH 7.1). Calcium Phosphate/DNA precipitate was then immediately 
dropped onto cells. Cells were returned to 37°C and 5% CO2 for 4hr followed by either a media 
change or passaging to 20mm Poly-L-Lysine coated coverslips and allowed to grow another 24-
48hr. Cells were transfected with plasmid DNA expressing either mCherry or a mixture of 
mCherry+SUMO+Ubc9 or mCherry+SENP1. For co-transfection of multiple plasmids, the total 
amount of plasmid DNA remained the same (25µg or 10µg) but comprised equal amounts of 
each of the different plasmids (1:1:1 or 1:1). Transfection efficiency was determined to be the 
percentage of cells expressing mCherry as judged by fluorescence microscopy. The transfection 
efficiency of every plate was checked for each experiment, and a plate was only used if the 
transfection efficiency exceeded 80%. 
3.3.6 Immunoprecipitations 
GFP-HCN2 IP from Hek cells: 100mm plates containing Hek cells were washed twice 
with ice-cold PBS (137mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4) 
followed by the addition of RIPA buffer (1% NP40, 50mM Tris pH 7.4, 150mM NaCl, 0.1% 
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SDS, 0.5% DOC, 20mM EDTA, protease inhibitor cocktail at 1:100 and 20mM NEM) to the 
plate. Cells were lysed on the plate for 30min on ice, rocking occasionally. A disposable cell 
scraper was used to scrape any remaining cell debris from the bottom of the plate, and the lysate 
was collected and transferred to a sterile tube. Cell debris was pelleted at 12,000rpm for 10min at 
4°C, and the supernatant was retained. Protein concentration was determined with a BCA assay. 
Immunoprecipitations (IP) were performed using the Classic Magnetic Co-IP Kit (Pierce), 
following the manufacturer’s instructions. Typically 1mg of protein was added to the beads and 
the protein was eluted from the beads in a volume of 100µl. HCN2 IP from mouse forebrain: 
1.5mg of the mouse membrane preparation with 5ug of anti-HCN2 antibody (Table 1) or IgG 
(Santa Cruz Biotechnology; sc-2028) were used in combination with the Classic Magnetic Co-IP 
Kit (Pierce), following the manufacturer’s instructions. Protein was eluted from the beads in a 
volume of 100µl and 20µl was used for one lane of an SDS-PAGE gel. 
3.3.7 Western Blotting 
Protein samples were run on an SDS-PAGE gel and transferred to a PDVF membrane 
using a semidry electroblotting system. A membrane was blocked for 1hr in a solution of 5% 
non-fat powdered milk in TBS (10mM Tris-HCl pH7.5, 150mM NaCl), washed for 10min in 
TTBS (1x TBS, 0.1% Tween 20), and then incubated overnight at 4°C with the primary 
antibody, diluted as described in Table 1, in 1% non-fat powdered milk in TTBS. The membrane 
was then washed 3x 5min each in TTBS and then incubated with the appropriate alkaline 
phosphatase conjugated secondary antibody, diluted in 1% non-fat powdered milk in TTBS for 
2hr at room temperature. Following incubation with the secondary antibody, the membrane was 
washed 3x 10min each and Immunstar AP substrate (BioRad) was added to the surface of the 
membrane, incubated 5min and then exposed to X-ray film to detect chemiluminescent signals. 
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In some cases, membranes were stripped and reprobed. Stripping involved washing the blot 2x 
5min each in mild stripping buffer (200 mM Glycine, 0.1% SDS, 1% (v/v) Tween 20, pH 2.2). 
The blot was then washed 2x 10min each in PBS and 2x 5min each in TTBS. The blot was then 
exposed to film to ensure the signal was removed. 
3.3.8 Patch Clamping Electrophysiology 
Coverslips (20mm) were dipped in ethanol, allowed to air dry, and incubated with Poly-
L- Lysine (50µg/ml in dH2O) at 37°C for 1hr. Coverslips were then washed once with sterile 
dH2O, air dried, and stored at 4°C. For an experiment, coverslips were seeded with 8x104 cells, 
and the next day coverslips containing transiently transfected cells were placed into a chamber 
and constantly perfused with extracellular saline solution (138mM NaCl, 5.6mM KCl, 2.6mM 
CaCl2, 1.2mM MgCl2, 10mM HEPES, 10mM Glucose, pH 7.4). Cells were visualized on an 
Olympus IX70 microscope and transiently transfected cells were identified by fluorescence and 
only those expressing mCherry were used for whole cell patch clamping experiments. A fire-
polished micropipette (Sutter Instruments, 6-8 MΩ) was filled with intracellular solution (10mM 
NaCl, 145mM KCl, 1mM MgCl2, 5mM HEPES, pH 7.2) and connected to an Axopatch 200B 
amplifier (Molecular Devices, Foster City, CA). To obtain a whole cell patch, a gentle negative 
pressure was used to form a ≥1GΩ seal between the cell membrane and the opening of the 
micropipette. Suction was used to rupture the cell membrane and recordings were taken from 
cells that maintained a seal ≥700 MΩ following rupture. Cells were held at -50mV using pClamp 
10 software and Ih was elicited using 5 sec hyperpolarizing voltage steps from -50mV to -120mV 
in 10mV increments with 4 seconds between each step. Steady-state peak current was measured 
by subtracting the initial fast leak current from the slowly activating Ih for each hyperpolarizing 
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voltage step. Conductance was calculated using the peak current at each voltage step (G= 
Ipeak/(Vm-Vrev); Vrev Ih= -35mV) and fitted to a first order Boltzmann equation. 
3.3.9 Cell Surface Biotinylation 
Hek-HCN2 cells plated on 60mm culture dishes were transiently transfected with either 
mCherry alone (control) or mCherry+SUMO+Ubc9. Cells were washed twice with ice-cold PBS, 
supplemented with 0.2mM CaCl2 and 1.5mM MgCl2 (PBS-CM) and incubated for 30min at 4°C 
with 0.5-1mg/ml of EZ-link Sulfo-NHS-SS-Biotin (Thermo Fisher, cat#21331). Cells were 
washed twice with ice cold PBS-CM, and residual biotin was quenched with PBS-CM plus 
100mM glycine for 15min at 4°C. Cells were washed once more with PBS-CM followed by lysis 
with ice cold RIPA buffer (1% NP40, 50mM Tris pH 7.4, 150mM NaCl, 0.1% SDS, 0.5% DOC, 
2mM EDTA, protease inhibitor cocktail at 1:100) for 30min on ice. A disposable cell scraper 
was used to remove any residual cell debris from the bottom of the plate, and the contents were 
transferred to a microcentrifuge tube. Cell debris was pelleted by centrifugation at 12,000 rpm 
for 10min. The supernatant was removed and immediately incubated for 2hr at 4°C with 
Neutravidin agarose resin (Pierce, cat #29201) with agitation. The lysate/resin mixture was 
centrifuged in a spin column (Thermo Fisher, cat #69725) at 1000xg for 2min. The flow through 
containing unbiotinylated intracellular proteins was retained for western blot analysis. The resin 
was washed three times in PBS supplemented with 1% NP40, and 0.1% SDS and three times in 
PBS supplemented with 0.1% NP40 and 0.5M NaCl, centrifuging at 500xg for 1min between 
each wash. Columns were capped, and biotinylated proteins were eluted from the beads by 
incubating for 1hr at room temperature with SDS loading buffer (50mM Tris-HCL pH 6.8, 
100mM DTT, 2% SDS, 0.1% Bromophenol blue, 10% glycerol). Columns were uncapped and 
centrifuged at 1000xg for 2min to collect the eluted extracellular proteins. Intracellular and 
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extracellular fractions were run on an SDS-PAGE gel and transferred to a PVDF membrane. The 
membrane was cut at ~50 kDa. The lower portion of the blot was probed with an anti-actin 
antibody (Santa Cruz Biotechnology) to confirm that there was no intracellular contamination in 
the extracellular samples. The top portion of the blot was dually probed with an anti-GFP 
antibody to detect the GFP-HCN2 channel, and an anti-Na+/K+-ATPase antibody to use for 
normalization (Table1). To confirm that expression of the Na+/K+-ATPase was not varying 
across treatment groups, samples from control and SUMO+Ubc9 transfected cells were run on a 
western blot. The blot was stained for total protein (SYPRO Ruby blot stain, Bio-Rad) and then 
probed for the Na+/K+-ATPase. The Na+/K+-ATPase signal was normalized by the total protein 
in the lane. A comparison of the normalized Na+/K+-ATPase signal across treatment groups 
indicated that there were no significant differences between control and SUMO+Ubc9 
transfected groups (Student’s t-test, p> 0.05, n=5). 
3.3.10 Image analysis and Quantification 
ImageJ was used to quantify signals from western blots. Optical density (OD) was 
measured using the Gel Analysis feature of the ImageJ software. Briefly, a rectangular box was 
drawn around the signal, and ImageJ software was then used to generate a profile plot of the 
relative intensity. A line was drawn to isolate the area under the curve and set the baseline, 
thereby subtracting the background, and the area under the curve was measured. In order to 
ensure images were not saturated, a series of exposures ranging from underexposed to 
overexposed was always obtained, and only intermediate exposures were quantified. Quantifying 
the fraction of SUMOylated GFP-HCN2 channels in Hek cells involved measuring a SUMO 
signal (entire GFP-HCN2 doublet) followed by stripping and reprobing the membrane to obtain a 
GFP signal (entire GFP-HCN2 doublet). In order to ensure that differences between treatment 
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groups were not due to differences created by stripping or variability in the length of SUMO 
relative to GFP film exposure, a complete set of treatment groups was present on each blot, and 
measures for each treatment group were obtained from the same exposure/film.  However, 
variability within a treatment group could be due to stripping and/or relative lengths of 
exposures. At best, these experiments are semi-quantitative and the fraction of SUMOylated 
channels in these cell lines may be over/under-reported with this method. Nevertheless, they 
suffice for detecting significant differences between treatment groups. 
3.3.11 Statistical analysis 
All data were analyzed using Prism 7 (Graphpad Software Inc.). Each data set was 
checked for normality and homogeneity of variance. Data were then analyzed using parametric 
statistical tests, including Student’s t-test and One-way ANOVA’s. In all cases, the significance 
threshold was set at p<0.05. Values that were greater than two standard deviations from the mean 
were considered statistical outliers and were excluded from the data set. ANOVA’s were 
followed by post hoc tests that either compared all groups to each other (Tukey’s) or to the 
control (Dunnett’s). Unless otherwise stated all values are presented as the mean ± SEM. 
3.4 Results 
3.4.1 Mouse HCN2 is SUMOylated In vivo 
To determine if the mouse HCN2 channel was SUMOylated in vivo, an antibody against 
HCN2 (Table 3.1) or IgG (negative control) was used to IP the channel from mouse forebrain 
membrane preparations that were or were not denatured, followed by western blot analyses using 
antibodies against HCN2, SUMO1 and SUMO2/3. Note that our anti-SUMO2/3 antibody does 
not discriminate between SUMO2 vs. SUMO3; therefore, the post-translational modification is 
referred to as SUMO2/3. Fig 3.1 illustrates that HCN2 channels were post-translationally 
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modified by both SUMO1 and SUMO2/3 in the mouse forebrain. Two bands at ~120 and 75 kDa 
were observed in the experimental preparations but not in the negative controls. The band at 
~120 kDa was previously identified as the HCN2 channel in mouse membrane preparations 
(Much, Wahl-Schott et al. 2003). It was observed in blots probed with anti-HCN2, anti-SUMO1 
and anti-SUMO2/3 in both non-denaturing and denaturing IP experiments, which suggests both 
SUMO1 and SUMO2/3 are covalently attached to HCN2 channels in the mouse forebrain. The 
~75kDa band was detected by the anti-SUMO antibodies, but not by the anti-HCN2 antibody, on 
the western blots containing IP experiments using nondenatured membrane preparations. Since 
this ~75 kDa band was not observed for the denaturing IP experiments, it most likely represents 
an unknown SUMOylated protein that noncovalently associates with HCN2 channels in the 
mouse forebrain. 
3.4.2 GFP-HCN2 Channels are SUMOylated in a Heterologous Expression System 
Previous work suggested that SUMOylation could be manipulated in tissue culture 
systems. We therefore generated a Hek-293 cell line stably expressing a GFP-HCN2 fusion 
protein (Hek-HCN2) as described in Materials and Methods. Note that GFP is at the N-terminus 
of the HCN channel. IP experiments were performed on parental Hek and Hek-HCN2 cell 
lysates using an anti-GFP antibody followed by western blot analyses with anti-GFP or anti-
HCN2 antibodies (Fig 3.2). Both the anti-GFP and the anti-HCN2 antibodies detected the same 
two bands between 150 and 250 kDa (Fig 3.2A). This doublet was not observed in the parental 
Hek cell line (Fig 3.2B). Together these data suggested that the doublet represented the GFP-
HCN2 channel. Previous studies on HCN2 channels expressed in Hek cells showed that the 
doublet represented two forms of the HCN2 channel (Much, Wahl-Schott et al. 2003, Akhavan, 
Atanasiu et al. 2005, Nazzari, Angoli et al. 2008). The slower migrating band contained a 
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complex N-glycosylation. The faster migrating band instead possessed a simple or no 
glycosylation. Complex N-glycosylation increased the efficiency of surface expression, but 
channels possessing only a subset of complex N-glycosylated subunits (Akhavan, Atanasiu et al. 
2005) or no complex N-glycosylated subunits (Nazzari, Angoli et al. 2008) could still be 
detected at the plasma membrane. Relative to past studies, the doublet detected in our 
experiments is larger, presumably due to the GFP tag. 
To determine if GFP-HCN2 channels were SUMOylated in our culture system, we 
performed the same anti-GFP IP with Hek-HCN2 cell lysates, followed by western blot analyses 
using anti-GFP (Fig 3.3, panel 1) and anti-SUMO2/3 (Fig 3.3, panel 2) antibodies. The data 
indicated that both antibodies recognized the same doublet between 150-250 kDa, suggesting 
that GFP-HCN2 channels were SUMOylated in Hek-HCN2 cells (here termed baseline 
SUMOylation). The SUMO signal was not due to similarly sized endogenous Hek proteins 
associating with GFP-HCN2 channels because the anti-SUMO2/3 antibody did not detect the 
doublet on western blots containing parental Hek cell lysates (Fig 3.3, panel 3). 
3.4.3 Transient Transfection of SUMO2 and Ubc9 Increases HCN2 Channel 
SUMOylation in a Hek Cell Line Stably Expressing Mouse HCN2 
We next wished to manipulate GFP-HCN2 channel SUMOylation in order to study its 
function. The conjugating enzyme, Ubc9, adds SUMO to a target protein. In some cases, Ubc9 is 
directed to a SUMOylation site by an external factor, such as a SIM domain or an E3 protein 
(Flotho and Melchior 2013). In other cases, Ubc9 directly recognizes a consensus sequence and 
adds SUMO to the K in the consensus sequence. Oftentimes the latter mechanism requires 
additional stabilizing interactions provided by other proteins or post-translational modifications; 
however, simply increasing the concentration of the Ubc9 enzyme can obviate their need at some 
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(but not all) consensus sequences, and previous work has demonstrated that SUMOylation of 
some target proteins can be increased in cell culture by overexpressing SUMO and Ubc9 (Dai, 
Kolic et al. 2009). Moreover, SENP has been shown to decrease SUMOylation of some proteins 
in a heterologous expression system (Dai, Kolic et al. 2009, Dustrude, Wilson et al. 2013) 
despite the fact that SENP has opposing functions: endopeptidase activity removes C-terminal 
amino acids to activate SUMO and promote target protein SUMOylation; isopeptidase activity 
removes SUMO conjugated to target proteins to promote deSUMOylation (Yeh 2009). 
In order to investigate whether or not we could manipulate SUMOylation of GFP-HCN2, 
the Hek-HCN2 cell line was transiently transfected with plasmids expressing mCherry, SUMO2, 
and Ubc9 or mCherry and SENP1. Control preparations were transfected with mCherry alone. 
To determine the fraction of HCN2 channels that were SUMOylated in each treatment group, 
GFP-HCN2 channels were immunoprecipitated from lysates using an anti-GFP antibody. 
Western blots containing the IP products were first probed with an anti-SUMO2/3 antibody. 
Chemiluminescence was used to detect the SUMO signal, and the optical density (OD) for the 
entire GFP-HCN2 doublet was measured with ImageJ (see Materials and Methods). After 
recording the SUMO signal, the antibody was stripped, and the same blot was reprobed with an 
anti-GFP antibody. Again, chemiluminescence was used to detect the GFP signal, and the optical 
density (OD) of the entire GFP-HCN2 doublet was measured. The fraction of SUMOylated 
channels was defined as the OD of the SUMO signal divided by the OD of the GFP signal (Fig 
3.4A). This non-linear, semi-quantitative method indicated that GFP-HCN2 SUMOylation was 
significantly increased in the SUMO+Ubc9 group, by an average of 50.7±16.01% relative to the 
control (Fig 3.4B). There was no significant difference in the amount of SUMOylated channels 
in cells transfected with SENP1 relative to control. This might suggest a low level of baseline 
39 
HCN2 SUMOylation in the Hek-HCN2 cell line. On the other hand, since SENP has two 
opposing functions it is also possible that the balance of these two functions doesn’t change upon 
SENP1 overexpression, leaving baseline SUMOylation unaltered. In sum, transient transfection 
of SUMO and Ubc9 increases HCN2 SUMOylation in Hek-HCN2 cells. 
3.4.4 HCN2 Channel SUMOylation Increases Ih Gmax 
Hyperpolarization of Hek-HCN2 cells to -120mV consistently elicited an average peak Ih 
of 710pA. This current was never detected in the parental Hek cell line (n>10); thus, it is 
mediated by GFP-HCN2 channels. We examined if/how SUMOylation affected Ih using whole 
cell patch clamp recordings on Hek-HCN2 cell lines that were transiently transfected with 
mCherry, mCherry+SUMO+Ubc9 or mCherry+SENP1. Transfected cells were identified by 
mCherry fluorescence. Ih was elicited by stepping the voltage from -50mV to -120 mV in 10 mV 
increments (Fig 3.5A). The data showed the treatment that produced a ~50% increase in HCN2 
SUMOylation (SUMO+Ubc9, Fig 3.4B) also produced a mean 77±18.8% increase in Ih Gmax 
relative to control (Fig 3.5B). Overexpression of SENP1 produced a detectable but not 
significant mean 31.7±14% decrease relative to control (Fig 3.5B), which was consistent with the 
finding that SENP1 did not significantly alter baseline SUMOylation of HCN2 channels. The 
change in Ih Gmax was not accompanied by any change in the voltage-dependence of activation 
(Fig 3.5C). Neither the mean V50, nor the mean slope of the activation curve were significantly 
different between control, SUMO+Ubc9, or SENP1 treatment groups (Fig 3.5C). Similarly, the 
time constant for activation was not significantly different between treatment groups (Fig 3.5A). 
In sum, increased SUMOylation of GFP-HCN2 produced a corresponding increase in Ih Gmax 
with no change in voltage dependence or kinetics of activation. 
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3.4.5 SUMOylation Increases HCN2 Channel Surface Expression 
We next tested whether or not the SUMOylation-dependent increase in Ih Gmax was 
accompanied by an increase in GFP-HCN2 channel surface expression. A biotinylation assay 
was used on Hek-HCN2 cells that were transiently transfected with mCherry or 
mCherry+SUMO+Ubc9. After 2 days, transfected cells were incubated with biotin, which binds 
to cell surface proteins. The cells were then lysed, and the biotinylated proteins were pulled out 
using Neutravidin. The unbiotinylated (intracellular) and biotinylated (extracellular surface) 
proteins were run on a western blot, and the blot was subsequently divided at ~50kDa. The 
portion of the blot containing proteins <50 kDa was probed with an antibody against actin. The 
~37kDa band corresponding to actin was only seen in the intracellular fractions, indicating there 
were no intracellular proteins contaminating the extracellular surface samples (Fig 3.6A). The 
section of the blot corresponding to proteins >50 kDa was dually probed with an anti-GFP 
antibody and an antibody against the Na+/K+-ATPase (Fig 3.6A). The doublet was detected with 
the anti-GFP antibody. The band at ~120 kDa represents the Na+/K+-ATPase. The OD of the 
GFP signal (entire GFP-HCN2 doublet) was normalized by that for the Na+/K+-ATPase signal. 
We observed a significant mean 70.6±18.2% increase in HCN2 surface expression in cells 
transfected with SUMO+Ubc9 relative to control (Fig 3.6B). Based on these findings, we 
concluded that the ~77% increase in Ih Gmax observed upon enhanced GFP-HCN2 channel 
SUMOylation was due, at least in part, to a ~70% increase in the surface expression of the GFP-
HCN2 channel. 
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3.4.6 Only One of Six Putative SUMOylation Sites is Necessary for the Increase in 
GFP-HCN2 Surface Expression and Ih Gmax Elicited by Overexpression of SUMO and 
Ubc9 
GFP-HCN2 channels can be SUMOylated in our culture system, and increased 
SUMOylation leads to an augmentation of Ih Gmax due, at least in part, to enhanced GFP-HCN2 
channel surface expression. Approximately 63% of all SUMOylation occurs within a 
SUMOylation consensus sequence (Hendriks, D'Souza et al. 2015), e.g. ΨKXD/E, with Ψ being 
a hydrophobic residue and X being any amino acid (Rodriguez, Dargemont et al. 2001, Sampson, 
Wang et al. 2001, Flotho and Melchior 2013). We next investigated if HCN channels possessed 
SUMOylation consensus sequences. SUMOplot freeware (www.abgent.com/sumoplot) was used 
to identify potential HCN SUMOylation sites for all mouse HCN channel isoforms and for the 
spiny lobster HCN channel. The amino acid sequences for all five channels were aligned, 
SUMOylation consensus sequences were highlighted for all isoforms and the probability of 
SUMOylation, as calculated by SUMOplot, was indicated (Fig 3.7). There were 6 putative 
HCN2 SUMOylation sites with probabilities ranging from 32% to 93%. One site was 
extracellular (K210) and was not considered further. Two of the five intracellular HCN2 
consensus sequences (K464 and K484) were observed in all mammalian HCN channel isoforms 
and in the lobster HCN channel. The other three consensus sequences were isoform/species 
specific. The consensus sequence containing K669 was exclusive to mouse HCN1 and HCN2 
channels. The consensus sequence that included K534 was found only in mouse HCN2 and 
lobster HCN channels. The consensus sequence containing K75 was unique to the mouse HCN2 
channel. Additional putative SUMOylation sites not observed in mouse HCN2 channels existed 
in other mouse and lobster HCN channel isoforms.  
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We next investigated if HCN2 consensus sequences were substrates for SUMOylation in 
our culture system. Because K534 and K669 showed a greater than 90% probability of 
SUMOylation (Fig 3.7), we chose to examine these first. These two sites were mutated 
individually and together by changing the positively charged K residue to a positively charged 
arginine (R), which should prevent SUMO conjugation without disrupting charge interactions 
(Feliciangeli, Bendahhou et al. 2007). Three Hek cell lines stably expressing the mutated 
channels were generated: Hek-HCN2 K534R+K669R, Hek-HCN2 K534R, and Hek-HCN2 
K669R. Each stable mutant cell line was transiently transfected with mCherry or 
mCherry+SUMO+Ubc9. After ~48hr the fraction of SUMOylated GFP-HCN2 channels was 
measured as previously described for Fig 3.4. Based on our semi-quantitative measures, the 
mutations did not appear to alter baseline HCN2-GFP SUMOylation in the mCherry treatment 
group (mean±SEM; wild-type = 0.31±0.025, K534R+K669R = 0.41±0.04, K534R = 0.31±0.02 
and K669R = 0.37±0.015; One-way ANOVA F(3,19) = 2.644, p = 0.0788). On the other hand, 
the mutations did disrupt the increase in HCN2-GFP SUMOylation normally elicited by 
SUMO+Ubc9 overexpression (Fig 3.8). Increased SUMOylation was no longer observed in the 
Hek-HCN2 K534R+K669R cell line (Fig 3.8A) or the Hek-HCN2 K669R cell line (Fig 3.8C); 
however, the Hek-HCN2 K534R cell line still displayed increased SUMOylation upon 
SUMO+Ubc9 overexpression (Fig 3.8B). In sum, the data suggest that overexpression of 
SUMO+Ubc9 increases SUMOylation at K669; furthermore, because SUMOylation is still 
observed when this site is mutated, at least one additional site on the GFP-HCN2 channel must 
be SUMOylated. 
We next examined Ih Gmax in the mutant cell lines. Consistent with the previous finding, 
we observed that mutating K669 but not K534 prevented the increase in Ih Gmax upon 
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SUMO+Ubc9 overexpression. Ih Gmax was not significantly different between the SUMO+Ubc9 
vs. control treatment groups in Hek-HCN2 K534R+K669R (Fig 3.9A) or Hek-HCN2 K669R cell 
lines (Fig 3.9C). However, in Hek-HCN2 K534R cells, a 58.2±16.1% increase in Ih Gmax was still 
observed in the SUMO+Ubc9 treatment group relative to control (Fig 3.9B). Together these data 
suggest that SUMOylation of K669 is responsible for the increase in Ih Gmax observed upon 
overexpression of SUMO+Ubc9. 
Lastly, we tested if mutating K669 prevented the increase in GFP-HCN2 surface 
expression normally elicited by overexpression of SUMO and Ubc9. Hek-HCN2 K669R cells 
were transiently transfected with mCherry or mCherry+SUMO+Ubc9 and the biotinylation assay 
was performed as described for Fig 3.6. The data indicated then when K669 was mutated, 
overexpression of SUMO and Ubc9 could no longer elicit an increase in GFP-HCN2 surface 
expression (Fig 3.10). In sum, the K669R mutation blocked the increase in SUMOylation, Ih 
Gmax and surface expression normally elicited by overexpression of SUMO+Ubc9. This suggests 
that enhanced SUMOylation at K669 augments GFP-HCN2 surface expression which in turn 
amplifies Ih Gmax. 
3.5 Discussion 
Ion channels are emerging as targets of SUMOylation. The extent to which different 
classes of ion channels are SUMOylated and the function and regulation of ion channel 
SUMOylation are only beginning to be investigated. Here we report, for the first time, that HCN 
channels are SUMOylated in vivo and in a heterologous expression system. IP experiments with 
mouse forebrain membrane preparations followed by western blotting showed that mouse HCN2 
channels were post-translationally modified by SUMO1, as well as SUMO2 and/or SUMO3 in 
vivo. HCN2 channels were also SUMOylated under baseline conditions in a Hek cell line stably 
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expressing a GFP-HCN2 construct, and transient transfection with SUMO and the SUMO-
conjugating enzyme, Ubc9, increased GFP-HCN2 channel SUMOylation above baseline. This, 
in turn, augmented GFP-HCN2 channel surface expression and produced a corresponding 
increase in Ih Gmax without altering the voltage dependence or kinetics of activation. Using site-
directed mutagenesis of HCN2 and Hek cell lines stably expressing mutant GFP-HCN2 
channels, we showed that SUMOylation at amino acid K669 was increased upon overexpression 
of SUMO+Ubc9, and this alone was responsible for enhanced GFP-HCN2 channel surface 
expression and augmentation of Ih Gmax. However, the K669R mutation, which prevented 
SUMOylation at this site, did not alter baseline SUMOylation of HCN2 channels, suggesting an 
additional site(s) on the GFP-HCN2 channel may be SUMOylated under baseline conditions. 
3.5.1 Ion Channels are SUMOylated In vivo 
The effect of SUMO modification on ion channels has become an area of increasing 
interest. Previous studies have identified additional ion channel targets of SUMOylation, and the 
effect of SUMOylation on these channels is quite diverse. For example, SUMO modification of 
Kv2.1 inhibits the current by speeding time-dependent inactivation and slowing recovery from 
inactivation in pancreatic cells (Dai, Kolic et al. 2009). However, SUMOylation of the same 
channel in hippocampal neurons results in a depolarized shift in the voltage dependence of 
activation, making the neurons more excitable (Plant, Dowdell et al. 2011). Studies looking at 
SUMOylation of the Kv1.5 channel found that it produced a shift in the voltage dependence of 
inactivation (Benson, Li et al. 2007). A recent study showed that in SENP2 null mice 
hyperSUMOylation of Kv7 channels diminished the M-current and resulted in neuronal 
hyperexcitability, leading to seizures and sudden death (Qi, Wang et al. 2014). In addition to 
altering the biophysical properties of ion channels, SUMOylation can alter their surface 
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expression. For example, kainite receptor SUMOylation leads to internalization of the receptor, 
and this effect can be enhanced by agonist binding and PKC phosphorylation (Martin, 
Nishimune et al. 2007, Konopacki, Jaafari et al. 2011, Chamberlain, Gonzalez-Gonzalez et al. 
2012). Here we have shown that HCN2 channel SUMOylation at K669 increases surface 
expression and Ih Gmax. It is important to note that the change in surface expression may not be 
the sole explanation for the change in Ih Gmax; though it was not examined here, changes in 
biophysical properties, such as an increase in the open probability (Po) of the channel, could also 
contribute to the observed increase in Ih Gmax. In addition, silent channels in the membrane could 
be activated by enhancing protein-protein interactions. 
3.5.2 HCN channels contain multiple SUMOylation Consensus Sequences 
The conjugating enzyme, Ubc9, adds SUMO to target proteins. In some cases, Ubc9 is 
directed to a SUMOylation site by an external factor, such as a SIM domain or an E3 ligase. In 
these instances, SUMOylation does not necessarily occur at a known consensus sequence (Flotho 
and Melchior 2013). In other cases, Ubc9 itself recognizes a consensus sequence and adds 
SUMO to the K in the consensus sequence. One study indicates that SUMOylation at known 
consensus sequences accounts for ~63% of all SUMOylation, although this may vary with the 
condition, e.g. normal growth conditions vs. heatshock (Hendriks, D'Souza et al. 2015). There 
are five predicted intracellular SUMOylation consensus sequences in HCN2 (Fig 3.7). Using 
Hek cell lines stably expressing wild type and mutant GFP-HCN2 channels, we clearly 
demonstrated that overexpression of SUMO and Ubc9 increased SUMOylation at only one of the 
five sites, K669. However, when K669 was mutated, GFP-HCN2 channel SUMOylation was still 
observed, suggesting additional sites were SUMOylated under baseline conditions. Since 
additional consensus sequences exist on both the GFP tag and the HCN2 channel, either or both 
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could contribute to the observed baseline SUMOylation. It is not clear why SUMOylation did 
not increase at these site(s) upon overexpression of SUMO and Ubc9. They may be maximally 
SUMOylated and/or additional proteins or regulatory mechanisms may be necessary for 
SUMOylation to occur. Alternatively, baseline SUMOylation may not occur at consensus 
sequences, in which case increasing SUMO and Ubc9 should have no effect. 
The five putative HCN2 consensus sequences ranged from being unique to HCN2 channels 
to being conserved across all mouse HCN and lobster channel isoforms. The consensus sequence 
that is known to be SUMOylated and which contains K669 is present exclusively in mouse 
HCN1 and HCN2 channels. Our data indicated that SUMOylation at K669 was not necessary to 
produce a functional current: Ih was not observed in whole cell patch clamp recording from 
parental Hek cells, but it was recorded in Hek cells stably expressing GFP-HCN2 channels with 
a K669R mutation that prevented SUMOylation at this site. Although K669 SUMOylation was 
not necessary, increased SUMOylation at K669 augmented GFP-HCN2 channel surface 
expression and Ih Gmax. These data suggest that SUMOylation at K669 may alter the rates of 
channel trafficking to and/or from the plasma membrane and/or alter channel retention in the 
plasma membrane. The surface expression of HCN1 channels can be rapidly adjusted in response 
to changes in activity, including seizures (Shah, Anderson et al. 2004, Noam, Zha et al. 2010, 
Jung, Warner et al. 2011). Activity can also regulate the SUMOylation of target proteins and the 
expression and localization of SUMO and the SUMOylation machinery in neurons (Jaafari, 
Konopacki et al. 2013, Loriol, Khayachi et al. 2013, Sun, Lu et al. 2014). Thus, it is possible that 
changes in activity might alter HCN channel surface expression by altering SUMOylation at this 
conserved site.  
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The putative HCN2 channel SUMOylation sites at K464 and K484 were observed in all 
mouse HCN channel isoforms and even in the lobster HCN channel (Fig 3.7), suggesting that 
they may play important functional roles. Both K464 and K484 are in the C-linker that connects 
the CNBD to the transmembrane region. The C-linker is necessary for channel trafficking and 
cAMP gating (Ulens and Siegelbaum 2003, Zagotta, Olivier et al. 2003, Zhou, Olivier et al. 
2004). The C-linker contains seven α-helices, A-F (Zagotta, Olivier et al. 2003); K464 lies 
between α-helices A and B while K484 lies between α-helices B and C. Since SUMOylation is 
thought to occur only in regions lacking secondary structure, it is noteworthy that both putative 
SUMOylation sites lie just outside of the α-helices. The A and B α-helices in one subunit are 
thought to interact with the C and D α-helices in a neighboring subunit (Zagotta, Olivier et al. 
2003). We have not yet tested whether these two SUMOylation sites are involved in channel 
folding, assembly and/or trafficking, but it may be that SUMOylation plays a fundamental role in 
these processes for all HCN channels. 
The K534 SUMOylation consensus site lies within the CNBD, which is also necessary 
for trafficking and cAMP gating (Akhavan, Atanasiu et al. 2005). According to a previous 
crystallography study of the solubilized C-terminus (Zagotta, Olivier et al. 2003), this site lies 
within α-helix A of the CNBD. The K534R mutation did not appear to alter baseline 
SUMOylation in our studies, nor did it prevent the increase in HCN2 SUMOylation observed 
upon overexpression of SUMO+Ubc9. Together these data suggest that K534 may not be 
SUMOylated in the mature channel. However, this site was assigned a high score by SUMOplot, 
and it is conserved across species, which often suggests functionality. Since SUMOylation is a 
dynamic and highly regulated process (Watts 2013), it may be that this site is transiently 
SUMOylated in response to a specific signal not mimicked in our experiments. 
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3.5.3 Potential SUMO-dependent HCN2 Channel Interactions 
SUMOylation can produce several distinct physiological consequences, but its primary 
function is to facilitate protein-protein interactions through the binding of a SUMO post-
translational modification on the target protein to a SUMO interaction motif (SIM) on the 
interacting partner protein (Hickey, Wilson et al. 2012). Other interaction motifs also exist 
(Flotho and Melchior 2013). We have demonstrated that HCN2 channel SUMOylation can 
regulate surface expression, and that (putative) HCN2 SUMOylation sites are located in domains 
that are important for channel trafficking and surface expression (Proenza, Tran et al. 2002, Tran, 
Proenza et al. 2002, Akhavan, Atanasiu et al. 2005, Nazzari, Angoli et al. 2008). Thus, while 
SIM containing interaction partners for HCN2 channels have not yet been identified, it seems 
likely that they may include trafficking and scaffold proteins. HCN2 synthesis and assembly 
begin in the ER where heavily glycosylated subunits associate through N- and C-terminal 
domains (Proenza, Tran et al. 2002, Tran, Proenza et al. 2002). Channels transit from the ER, 
through the Golgi and to the plasma membrane via their interactions with a host of proteins that 
mediate vesicular trafficking. Plasma membrane HCN2 channels can be recycled. Recycled 
HCN channels are stored in the endosome recycling compartments below the plasma membrane 
until a signal, such as Phospholipase D activation, triggers insertion back into the plasma 
membrane (Hardel, Harmel et al. 2008). SUMOylation could be involved at any of these 
trafficking stages. Scaffold and trafficking proteins are known to interact with three distinct 
domains in the C-terminus of the HCN2 channel: the C-linker, the CNBD, and the ~230 amino 
acids distal to the CNBD (Kimura, Kitano et al. 2004, Santoro, Wainger et al. 2004, Lewis, 
Schwartz et al. 2009, Han, Noam et al. 2011). S-SCAM, mint, and talamin are scaffold and 
trafficking proteins that form an assemblage with HCN2 channels through unknown interactions 
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involving the distal ~230 amino acids. SUMOylation site K669 is located in this distal fragment, 
suggesting that SUMOylation at this site may enhance surface expression by promoting these 
assemblages (Han, Noam et al. 2011). SUMOylation in the C-linker and/or the distal fragment 
could also potentially promote or prevent the binding of trafficking/scaffolding proteins like 
TRIP8b (Santoro, Wainger et al. 2004, Lewis, Schwartz et al. 2009, Han, Noam et al. 2011) and 
S-SCAM (Kimura, Kitano et al. 2004) to the CNBD. 
3.5.4 HCN Channel SUMOylation and Neurological Disorders 
Multiple neurological disease states may be linked to aberrant SUMOylation. Normally 
SUMOylation of α-synuclein promotes a functional, soluble conformation of the protein, but 
deSUMOylation leads to α-synuclein aggregation and cytotoxicity, which are hallmarks of 
Parkinson’s Disease (Eckermann 2013). Also, the parkin gene is frequently mutated in autosomal 
recessive Parkinson’s patients (Guerra de Souza, Prediger et al. 2016). Parkin is a ubiquitin 
ligase that mediates the degradation of misfolded mitochondrial proteins. SUMOylation 
regulates parkin shuttling from the cytosol to the nucleus, thereby controlling its availability at 
the mitochondria (Um and Chung 2006). Alzheimer’s disease is characterized by the formation 
of neurofibrillary tangles and amyloid-beta (Aβ)-containing plaques. Two proteins closely 
associated with these features, amyloid precursor protein (APP) and tau, have recently been 
identified as targets of SUMOylation (Hoppe, Salbego et al. 2015). Their improper 
SUMOylation could contribute to misfolding and aggregation (Flotho and Melchior 2013). 
Altering the expression of enzymes in the SUMOylation pathway can lead to seizures due, at 
least in part, to hyperSUMOylation of Kv7 channels (Qi, Wang et al. 2014).  If SUMOylation is 
globally disrupted in a given disease, then multiple targets could be affected, including HCN2 
channels. Indeed, HCN2 channel activity is progressively reduced in a mouse model of 
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Parkinson’s disease leading to altered pacemaking in globus pallidus neurons (Chan, Glajch et al. 
2011), and altered HCN2 channel expression has been associated with seizures in a variety of 
instances (Ludwig, Budde et al. 2003, DiFrancesco, Barbuti et al. 2011, Nakamura, Shi et al. 
2013, DiFrancesco and DiFrancesco 2015). Future studies on the function and regulation of 
HCN channel SUMOylation could provide important insights into HCN2 channel dysfunction in 
these disease states. 
  
51 
 
 
Figure 3.1 Mouse HCN2 is SUMOylated in vivo 
Mouse forebrain non-denatured (A) and denatured (B) membrane fractions were used in 
immunoprecipitation experiments (IP) with an antibody against HCN2 or IgG (negative control). 
Western blots containing the IP products were probed for HCN2, SUMO1, and SUMO2/3. The 
experiment was repeated three times using the brains from three different mice. Representative 
western blots are shown from a single experiment. The red dots indicate non-specific products 
pulled down in the IP. The single band at ~120kDa represents HCN2 channels. The asterisk 
indicates a non-covalently bound, SUMOylated protein 
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Figure 3.2 Establishing a culture system to investigate HCN2 channel SUMOylation 
Cell lysates from a Hek cell line stably expressing GFP-HCN2 channels (A) and the parental 
Hek cell line (B) were used in IP experiments with an antibody against GFP. Western blots (WB) 
containing the lysate (L) and IP products (IP) were then probed with anti-HCN2 and anti-GFP 
antibodies. A doublet was recognized by both antibodies in the stably transfected but not parental 
Hek cell line, suggesting that the doublet represents GFP-HCN2 channels. The band present at 
50kDa in the IP lanes corresponds to the heavy chain of the anti-rabbit antibody used in the IP 
experiment. The anti-rabbit secondary antibody used in the GFP western blot produced a strong 
signal. The anti-mouse secondary antibody used in the HCN2 western blot produced a much 
weaker signal 
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Figure 3.3 GFP-HCN2 channels are SUMOylated in Hek-HCN2 cells 
Cell lysates from the Hek-HCN2 cell line were used in IP experiments with an antibody against 
GFP. Western blots containing the IP products were then probed with an anti-GFP antibody or an 
anti-SUMO2/3 antibody. Parental Hek cell lysates were also probed with the anti-SUMO2/3 
antibody. The anti-SUMO2/3 antibody recognized the GFP-HCN2 doublet in the Hek-HCN2 cell 
line, but not in the parental cell line, suggesting that GFP-HCN2 channels are SUMOylated 
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Figure 3.4 Transient transfection with SUMO and Ubc9 leads to an increase in GFP-
HCN2 channel SUMOylation 
The stable Hek-HCN2 cell line was transiently transfected with mCherry (control), or 
mCherry+SUMO+Ubc9, or mCherry+SENP1. Two days after transfection, cell lysates were 
used in IP experiments with an anti-GFP antibody. IP products were resolved with SDS-PAGE 
and transferred to western blots (WB). Blots were probed with an anti-SUMO2/3 antibody. After 
recording the result, blots were stripped and reprobed with an anti-GFP antibody. (A) 
Representative blots showing typical chemiluminescent signals for the GFP-HCN2 channel 
doublet after probing with the anti-SUMO2/3 antibody (upper panel) followed by stripping and 
re-probing with the anti-GFP antibody (bottom panel). Note that the amount of IP product varied 
between experiments but not across treatment groups as determined by measures of the GFP 
OD’s (One-way ANOVA, F(2,16)= 0.1285; p=0.8804). (B) The fraction of SUMOylated HCN2 
channels in each treatment group (SUMO doublet OD÷GFP doublet OD, see text) is plotted as 
the mean+SEM. The treatment and the n are shown below each plot. Each n represents a single 
plate that was transfected and carried through the experiment to produce a single lane on a 
western blot. Asterisk represents a statistically significant difference from control (One-way 
ANOVA with a Dunnett’s post-hoc, F(2,16)= 4.121; p=0.0360) 
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Figure 3.5 Increased HCN2 channel SUMOylation augments Ih Gmax 
Ih was measured in Hek-HCN2 cells transiently transfected with either mCherry (control), 
mCherry+SUMO+Ubc9, or mCherry+SENP1. For each treatment group, data were pooled from 
≥ 3 transfections. (A) Representative traces for each treatment group, elicited by stepping the 
voltage from -50mV to -120mV in 10mV increments. Scale bars, 500ms and 200pA. The 
kinetics of activation at -120mV were not altered across treatment groups. Mean activation time 
constants: control, 400.9 ± 23.01; SUMO+Ubc9, 407.3 ± 33.67; SENP1, 497.4 ± 50.79; One-
way ANOVA, F(2,32)= 2.224; p=0.1246. (B) Plots of Ih Gmax for each treatment group. Each 
data point represents a single cell. Bar represents the mean. Transfection with SUMO+Ubc9 
significantly increased Ih Gmax relative to SENP1 and control treatment groups (asterisks, p<0.05; 
One-way ANOVA with Tukey’s post-hoc, F(2,28)= 13.23; p< 0.0001). (C) Plots of voltage 
dependence of activation. Each data point represents the mean ± SEM. There were no significant 
differences between treatment groups for mean V50 (control, -93.88 ± 1.12; SUMO+Ubc9, -91.6 
± 1.29; SENP1, -87.8 ± 3.03; One-way ANOVA, F(2,32)= 3.006; p=0.0636) or mean slope 
(control, -6.61 ± 0.29; SUMO+Ubc9, -7.42 ± 0.41; SENP1, -6.84 ± 0.4; One-way ANOVA, 
F(2,32)= 1.439; p= 0.252) 
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Figure 3.6 Increased SUMOylation augments HCN2 channel surface expression 
GFP-HCN2 channel cell surface expression was monitored using a biotinylation assay. 
Hek-HCN2 cells were transiently transfected with mCherry alone or mCherry+SUMO+Ubc9. 
Two days after transfection cultures were biotinylated and cell surface proteins were isolated 
from cell lysates using Neutravidin. Both the intracellular and cell surface fractions were run on 
a western blot and probed with antibodies recognizing GFP, Na+/K+-ATPase, and Actin. (A) 
Representative western blots. (B) Plots depicting average normalized GFP-HCN2 channel 
surface expression (GFP doublet OD÷Na+/K+-ATPase OD). The treatment and the n are shown 
below the graph. Each n represents a single plate that was transfected, biotinylated and carried 
through the experiment to produce a single lane on a western blot. Asterisk indicates significant 
difference between treatment groups (Student’s t-test, p<0.05) 
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Figure 3.7 Identification of HCN2 channel SUMOylation sites 
Amino acid sequences for the vertebrate and invertebrate HCN channel were aligned: mouse 
HCN1 (NP_034538), mouse HCN2 (NP_032252), mouse HCN3 (NP_032253), mouse HCN4 
(NP_001074661), spiny lobster HCN (ABI94038). Putative SUMOylation sites predicted by 
SUMOplot freeware are indicated in blue (not mutated this study) or red (mutated in this study). 
The six transmembrane domains (yellow) and CNBD (blue) have been highlighted 
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Figure 3.8 Overexpression of SUMO and Ubc9 enhances SUMOylation at K669 
The three mutant cell lines (A-C) were transiently transfected with mCherry or 
mCherry+SUMO+Ubc9. Cell lysates were used in IP experiments with anti-GFP antibodies. 
Western blots containing IP products were probed with the anti-SUMO2/3 antibody, stripped and 
reprobed with the anti-GFP antibody. Top Panel: Representative blots showing the GFP-HCN2 
doublet that was measured. Bottom Panel: Plots of the fraction of SUMOylated GFP-HCN2 
channels in each mutant cell line, mean+SEM. The treatment and the n are shown below the 
graph. Each n represents one plate that was transfected and carried through the experiment to 
produce a single lane on a western blot. Asterisk, significantly different (Student’s t-test, p<0.05) 
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Figure 3.9 Enhanced SUMOylation at K669 augments Ih Gmax 
Ih Gmax was measured following transient transfection with mCherry or mCherry+SUMO+Ubc9 
in the three mutant cell lines (A-C). Top panel: Representative traces for each treatment group 
for each mutant cell line. Scale bars, 500 ms, and 500 pA, Bottom Panel: Plots of normalized Ih 
Gmax (Gmax ÷ mean mCherry Gmax) for each mutant cell line. Ih Gmax was normalized to account 
for differences in overall expression of the HCN2 channels between the different mutant cell 
lines, most likely due to difference in the copy number of the plasmid integrated into the 
genome. Each data point represents a single cell. Asterisk, significantly different (Student’s t-test 
p<0.05, recordings were pooled from ≥ 3 separate transfections) 
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Figure 3.10 Enhanced SUMOylation at K669 increases GFP-HCN2 channel surface 
expression 
The K669R mutant cell line was transiently transfected with mCherry or 
mCherry+SUMO+Ubc9, followed by the biotinylation assay to measure GFP-HCN2 surface 
expression. (A) Representative blots probed with anti-GFP and anti-Na/K ATPase antibodies (B) 
Plots of normalized GFP-HCN2 channels in each treatment group.  The treatment and the n are 
shown below the graph. Each n represents a single plate that was transfected, biotinylated and 
carried through the experiment to produce a single lane on a western blot. There was no 
significant difference between treatment groups (Student’s t-test, p=0.5606) 
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Table 3.1 Primary Antibodies 
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Table 3.2 Site directed mutagenesis primers 
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4 CHAPTER 2: TONIC NM DOPAMINE CAN PERMIT OR PREVENT 
SUMOYLATION-MEDIATED ACTIVITY-DEPENDENT REGULATION OF 
IONIC CURRENTS 
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4.1 Abstract 
Homeostatic mechanisms can co-regulate ionic conductances to stabilize neuronal 
activity features. In the Lateral Pyloric neuron (LP) of the crustacean stomatogastric ganglion, a 
positive correlation between the transient potassium current (IA) and the hyperpolarization-
activated current (Ih) stabilizes activity phase. Previous studies indicated a slow mechanism 
produced a positive correlation between the transcripts encoding the channels mediating LP IA 
and Ih. Here we show a second mechanism exists whereby activity can rapidly co-regulate the 
currents by controlling the level of post-translational modification by Small Ubiquitin-like 
Modifier (SUMO). Changes in activity produced opposing changes in the SUMOylation 
associated with LP IA and Ih. SUMOylation had opposing effects on LP IA and Ih amplitudes. 
Thus activity-dependent SUMOylation specified a positive correlation between LP IA and Ih. 
Tonic nM DA reconfigured the targets of the SUMOylation machinery, suggesting that the 
composition of modulatory tone will permit or prevent the correlations specified by activity-
dependent SUMOylation. 
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4.2 Introduction 
Homeostatic processes stabilize neuronal output by producing compensatory changes in 
synaptic strengths and ionic current densities in response to altered activity (O'Leary and Wyllie 
2011, Davis 2013). One of the earliest demonstrations that neuronal output could be stabilized by 
adjusting ionic current densities in an activity-dependent manner was a computational model 
based on the lateral pyloric neuron (LP) that produces rhythmic bursts of action potentials (Fig 
4.1A). The computational neuron attained a robust output by modulating the maximal 
conductances (Gmax) of its seven ionic currents in response to activity perturbations that altered 
Ca2+ concentration (LeMasson, Marder et al. 1993). Subsequent experimentation demonstrated 
that compensatory changes in current densities may be evoked by a variety of activity 
perturbations produced by physically isolating network neurons (Turrigiano, Abbott et al. 1994), 
chronic pharmacological applications (Desai, Rutherford et al. 1999, Ishikawa, Mu et al. 2009, 
O'Leary, van Rossum et al. 2010, Driscoll, Muraro et al. 2013) and genetic knock-out/over-
expression of a specific conductance(s) (Linsdell and Moody 1994, Swensen and Bean 2005, 
Peng and Wu 2007). These experimental approaches inevitably highlighted slow mechanisms 
that operated at the level of transcription and/or translation (Driscoll, Muraro et al. 2013, 
Kirchheim, Tinnes et al. 2013, Pozzi, Lignani et al. 2013), which led to computational models of 
activity homeostasis that used slow feedback control mechanisms to regulate ionic current 
densities (Golowasch, Casey et al. 1999, Olypher and Prinz 2010, O'Leary, Williams et al. 2014). 
The term Homeostatic Intrinsic Plasticity (HIP) is used to describe slow, activity-dependent, 
compensatory adjustments in ionic current densities that persist beyond the initiating stimuli 
(Mitchell and Johnson 2003). While HIP appears to stabilize neuronal output over the long-term, 
it cannot offset the fast positive feedback associated with Hebbian learning (Zenke, Gerstner et 
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al. 2017). There are examples of rapid compensatory changes in ionic current densities that 
stabilize neuronal activity over shorter timescales (van Welie, van Hooft et al. 2004, Fan, Fricker 
et al. 2005, Steinert, Robinson et al. 2011). These mechanisms are thought to act post-
translationally and produce transitory alterations in current densities, as such, they do not fall 
under the heading of plasticity. Transient changes that do not significantly outlast their stimuli 
are classified as modulation (Mitchell and Johnson 2003), and here we use the term Homeostatic 
Intrinsic Modulation (HIM) to mean rapid and transitory, activity-dependent modifications in 
ionic current densities that compensate for changes in activity. 
We have been studying HIM in LP, a component of the pyloric pattern generating circuit 
which produces a constant rhythmic output (Marder and Bucher 2007). Although the frequency 
of the cyclic pyloric output can vary, the phase relationships of the neurons within each rhythmic 
cycle are invariant (Bucher, Prinz et al. 2005, Goaillard, Taylor et al. 2009), suggesting that a 
homeostatic mechanism(s) maintains LP activity phase. Covariation of ionic conductances can 
maintain specific neuronal activity features (Hudson and Prinz 2010, Soofi, Archila et al. 2012, 
Zhao and Golowasch 2012). LP phase depends, in part, on the balance between the transient 
potassium (IA) and hyperpolarization activate (Ih) currents (Harris-Warrick, Coniglio et al. 1995, 
Zhao and Golowasch 2012). These two conductances are positively correlated in LP neurons 
(Temporal, Desai et al. 2012). We previously demonstrated that reducing LP IA with bath-
applied 5µM DA (Rodgers, Fu et al. 2011, Krenz, Hooper et al. 2013) or 4mM 4-AP (Krenz, 
Rodgers et al. 2015) altered LP phasing, but then, phase recovered over minutes. Further 
investigation showed that when the preparation was superfused with 5nM DA, incremental bi-
directional changes in activity produced corresponding changes in LP Ih with a time constant of 
~10min (Krenz, Rodgers et al. 2015). The phase recovery observed in our experiments could be 
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explained as follows: the reduction in IA produced an incremental change in activity, which in 
turn led to a similar reduction in Ih through a DA-enabled, Ca2+-dependent mechanism, and this 
restored the correlation. These findings are somewhat perplexing. Presumably, manipulation of 
non-IA currents could produce a comparable change in activity, leading to an incremental 
reduction in LP Ih that would then disrupt the correlation between IA and Ih. One possibility is 
that IA and Ih are similarly regulated by activity. But if this were true, then a given change in 
either of the two conductances must alter activity in the same manner to maintain the correlation. 
This seems unlikely given that IA and Ih are opposing conductances. It is reasonable to think that 
HIP and HIM are guided by similar principles. Studies on HIP show that multiple currents are 
simultaneously correlated (Zhao and Golowasch 2012) and that current compensation is non-
reciprocal (Kim, Vienne et al. 2017). A recent computational model of HIP that required a 
neuron to preserve a set Ca2+ concentration was able to successfully maintain conductance 
correlations and activity features by regulating ion channel transcription in an activity-dependent 
fashion (O'Leary, Williams et al. 2014). A major limitation of this model was that it assumed 
functional protein levels were determined solely by mRNA abundance. This model could be 
improved by incorporating compensatory, activity-dependent post-translational mechanisms, but 
the molecular pathways involved in HIM are currently unknown. 
In this study, we delve into the molecular mechanism responsible for the correlation 
between LP IA and Ih and how it is regulated by modulatory tone. We reasoned that the Small 
Ubiquitin-like Modifier (SUMO) could be involved in HIM because it has been shown to 
regulate the surface expression of the Hyperpolarization-activated, Cyclic Nucleotide-gated 
(HCN) channels that mediate Ih (Parker, Welch et al. 2016). SUMO is a peptide that is post-
translationally conjugated to target proteins in order to alter their protein-protein interaction 
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(Flotho and Melchior 2013). Target protein SUMOylation states are dynamically regulated by 
the opposing actions of conjugating and deconjugating enzymes (Flotho and Melchior 2013). 
The SUMO system is thought to coordinately regulate groups of proteins that are functionally 
related (Hay 2005, Jentsch and Psakhye 2013, Seifert, Schofield et al. 2015), and it has the 
potential to coordinate fast and slow negative feedback loops by simultaneously decorating 
proteins mediating HIM, e.g., ion channels, and HIP, e.g., transcription factors. Neuronal activity 
and activation of G-protein coupled receptors can alter the location and activity of the 
SUMOylation machinery (Jaafari, Konopacki et al. 2013, Loriol, Khayachi et al. 2013, Loriol, 
Casse et al. 2014), and target proteins can be SUMOylated in an activity-dependent manner 
(Chamberlain, Gonzalez-Gonzalez et al. 2012, Sun, Lu et al. 2014). SUMO is emerging as an 
important regulator of synaptic plasticity and in some cases, it is necessary for long-term 
potentiation (LTP) (Jaafari, Konopacki et al. 2013), long-term depression (LTD) (Chamberlain, 
Gonzalez-Gonzalez et al. 2012), and synaptic scaling (Craig, Jaafari et al. 2012); thus, the 
SUMO system also has the potential to coordinate positive and negative feedback loops. Here we 
explore the function of SUMOylation in specifying the correlation between LP IA and Ih, and the 
permissive role of tonic 5nM DA in this process. 
4.3 Methods 
4.3.1 Animals 
California spiny lobsters, Panulirus interruptus, were purchased from Marinus Scientific 
(Long Beach, CA) and Catalina Offshore Products (San Diego, CA). Lobsters were maintained 
at 16◦C in aerated and filtered seawater. Animals were anesthetized on ice before dissection. 
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4.3.2 Chemicals 
Tetrodotoxin (TTX) was purchased from Tocris Bioscience (Bristol, UK), Tween20 was 
purchased from Fisher Scientific and all other chemicals were purchased from Sigma-Aldrich 
(St. Louis, MI, USA). DA was made fresh every 30min to minimize oxidation. 
4.3.3 Antibodies 
An antibody against the lobster HCN channel (anti-HCN) was synthesized. DNA 
corresponding to amino acids 362-390 (Genbank Accession# DQ865250) was cloned into a 
PGex vector (Amersham) and the peptide was isolated according to the manufacturer’s 
instructions. The peptide served as an immunogen and was injected into a rabbit. Serum obtained 
from an immunized rabbit was affinity purified on a column containing the antigenic peptide. 
Antibody specificity was demonstrated in IP and western blot experiments using Hek cells that 
stably overexpressed the lobster HCN channel (Supp Fig 4.2).  
Bethyl Laboratories (Montgomery, TX) was contracted to produce a custom affinity 
purified goat polyclonal antibody against a peptide corresponding to ORF-J (5’-
CVGGPPLHPSAITTTNTNTAT-3’) of the shal (Kv4) protein (Baro, Quinones et al. 2001). 
Anti-ORF-J and a previously validated antibody against a different region of the lobster Kv4 
protein (Baro, Ayali et al. 2000) recognized the same ~75kD band on western blots containing 
lobster nervous system protein lysates (Supp Fig 4.2).  
All other antibodies were commercially obtained as indicated in the text and validated as 
indicated in Supp Fig 4.1 and Supp Fig 4.2. All secondary antibodies were obtained from 
Jackson ImmunoResearch Laboratories (West Grove, PA). 
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4.3.4 STNS Dissection and LP Identification 
The stomatogastric nervous system (STNS) was dissected and pinned into a Sylgard dish. 
The stomatogastric ganglion (STG) was desheathed and isolated with a Vasoline well. The STG 
was constantly superfused with aerated Panulirus saline (479mM NaCl, 12.8mM KCl, 13.7mM 
CaCl2, 39mM Na2SO4, 10mM MgSO4, 2mM glucose, 4.99mM HEPES, 5mM TES at pH 7.4). 
Extracellular recordings were obtained by placing stainless-steel pin electrodes, connected to a 
differential AC amplifier (A-M Systems, Everett, WA, USA), directly against the pyloric dilator 
nerve (pdn) and lateral ventricular nerve (lvn) and insulating them with Vasoline. Intracellular 
somatic recordings were obtained using a high resistance electrode filled with 3M KCl (20–30 
MΩ) and an Axoclamp 900A amplifier (Axon Instruments, Foster City, CA, USA). Neurons 
were identified by correlating action potentials from somatic intracellular recordings with 
extracellularly recorded action potentials on identified motor nerves, and by their characteristic 
shape and timing of oscillations. The process of dissection and cell identification took ∼2–4h. 
4.3.5 Somatic Two-Electrode Voltage Clamp (TEVC) 
All experiments were performed at 19–22◦C as measured with a temperature probe in the 
bath. Temperature changed by less than 1◦C during an experiment. For TEVC experiments LP 
was impaled with two low resistance glass microelectrodes filled with 3M KCl (7-10MΩ) 
connected to an Axoclamp 900A amplifier. The STG was superfused with Panulirus saline 
containing TTX (100nM) to block voltage-dependent Na+ channels. No other ion channel 
blockers were included. 
LP Ih was elicited from a holding potential of -50mV using a series of 4sec voltage steps 
from the holding potential of -50mV to -120mV in 10 mV increments with 6sec between each 
step. LP Ih steady state peak current was measured by subtracting the initial fast leak current 
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from the slowly developing Ih at the end of each voltage step. Current was converted to 
conductance using Erev=-35mV (Kiehn and Harris-Warrick 1992) and fitted to a first order 
Boltzmann equation.  
LP IA was measured as the peak difference current between a 50ms depolarizing step to 
+40mV that was preceded by a 200msec prepulse to -90mV vs. -40mV (Baro, Levini et al. 
1997). IA is largely blocked by 4mM 4-AP (Tierney and Harris-Warrick 1992). In our 
experiments, 5mM 4-AP blocked approximately 85-90% of the peak current. The current that 
remained in 4-AP appeared to be a mix of inward and outward currents. An inward current 
observed from ~ -10 to +20mV could be blocked by 200 M Cd2+ and was most likely the 
previously described small (~6nA), transient P/Q type calcium current that has a steady-state 
inactivation profile highly similar to IA in crustacean motor neurons (Ransdell, Temporal et al. 
2013). Ca2+ currents could not be blocked since we were studying activity-dependent changes in 
IA and Ih. The outward currents observed in 4-AP were presumably residual IA, IKCa and IKD. The 
small mixed current that remained in 4-AP was not obviously modulated by activity in the 
presence or absence of 5nM DA (Kruskal Wallis test, no DA: p=0.9286, n=3; 5nM DA: 
p=0.5107, n=3), suggesting that the activity- and DA-dependent changes we observed 
represented alterations in peak IA. 
4.3.6 SUMO cloning 
A complete Panulirus interruptus SUMO cDNA was isolated using a combination of 
degenerate PCR and RACE. Total RNA was isolated from lobster nervous system tissue with 
Trizol and used as the template in a reverse transcription with Superscript according to 
manufacturer’s instruction. The resulting cDNA served as a template in a degenerate PCR and 
RACE reactions (Baro, Cole et al. 1994). Degenerate primers (Table 4.1) were designed based 
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on an alignment of Drosophila melanogaster Smt3 (Genbank accession:NM_058063), Mus 
musculus SUMO 2 (Genbank accession:NM_133354), and Mus musculus SUMO 3 (Genbank 
accession:BC115488). The predicted ~180bp PCR product was gel isolated and cloned into a 
pDrive vector (Qiagen) and sequenced. Lobster specific RACE primers (Table 4.1) were 
designed. The 3’ end of the SUMO transcript was obtained using lobster specific forward 
primers (Table 4.1; Specific For1 and For2) and a SMARTer RACE kit (Clontech), following the 
manufacturer’s instructions. The 5’ end of the SUMO transcript was obtained using lobster 
specific reverse primers (Table 4.1; Specific Rev1 and Rev2) and a FirstChoice RLM RACE Kit 
(Ambion). All sequencing was performed by the GSU DNA core facility, and sequences were 
analyzed and manipulated with the Lasergene 10 suite of DNASTAR software. 
4.3.7 Tat-SUMO Peptide Synthesis 
cDNA representing the activated form of lobster SUMO, i.e. ending in diglycine (Supp 
Fig 4.1), was obtained in a PCR using lobster specific primers (Table 4.1; Tat-SUMO For and 
Rev). Standard recombinant DNA techniques were used to clone the predicted 274bp gel isolated 
PCR product into the EcoRI site of the pcDNA3 Tat HA vector (a gift from Matija Peterlin 
(Cujec, Okamoto et al. 1997); Addgene plasmid #14654), thereby creating an N-terminal Tat-
HA-His tagged SUMO construct. In order to synthesize the Tat-SUMO peptide, the plasmid was 
transformed in BL21-CodonPlus (DE3)-RIPL E. coli (Agilent). A single isolated colony was 
grown overnight in 200ml of broth containing ampicillin (100µg/ml) at 37◦C with agitation. The 
200ml overnight culture was then added to 1L of broth containing 500µM IPTG to induce 
expression of the peptide, and further incubated for 5hr. Cells were pelleted at 8,000rmp for 
10min at 4◦C, and the pellet was washed with ice cold PBS (137mM NaCl, 2.7mM KCl, 10mM 
Na2HPO4, 1.8mM KH2PO4, pH7.4). Pelleted cells were resuspended in 20ml of Buffer Z (8M 
76 
Urea, 100mM NaCl, 20mM HEPES, pH8) and sonicated on ice using a 10sec “on” 30sec “off” 
protocol at 15% amplitude for a total of 10min. Sonicate was cleared by centrifuging at 
12,000rpm for 10mins at 4◦C. Cleared sonicate was equilibrated with 10mM imidazole and 
incubated with 10ml of Ni-NTA agarose resin (Qiagen) at 4◦C for 1hr. Resin was washed with 
100ml of Buffer Z equilibrated with 10mM imidazole. Peptide was eluted with incrementally 
increasing concentrations of imidazole (100, 250, 500mM, and 1M; 10ml each) and the buffer 
was exchanged for PBS with 10% glycerol using PD-10 desalting columns (GE Healthcare). 
Peptide concentration was determined by BCA assay (Pierce). 
4.3.8 Immunoprecipitation and Western Blots 
Lobster nervous system lysates were prepared by homogenizing lobster nervous system 
tissue in NP-40 lysis buffer (50mM Tris HCl pH7.4, 150mM NaCl, 1% NP-40, 20mM NEM, 
protease inhibitor cocktail at 1:100). Homogenate was incubated at 4◦C with agitation and then 
centrifuged at 12,000rpm for 20min to pellet cell debris. Protein concentration was determined 
by BCA assay (Pierce). Immunoprecipitation (IP) was performed using Dynabeads Protein G 
(Invitrogen). Briefly, 10µg of antibody was incubated with the beads in 0.1M Na acetate pH 5.3 
for 1hr at room temperature with agitation. Beads were washed three times with 0.1M Na acetate 
pH 5.3 plus 0.01% Tween-20, 2mg of cell lysate was added to the beads and the mixture was 
incubated for 90min at room temperature with agitation. Finally, the beads were washed three 
times with PBS plus 0.01% Tween-20 and eluted in 20μl of 50mM Glycine pH 2.8 by heating to 
70◦C for 10min. Western blot experiments were as previously described (Parker, Welch et al. 
2016). Primary antibody concentrations used for western blots were as follows: anti-HCN, 
1:5000, anti-ORF-J, 1:4000, anti-SUMO, 1:4000. 
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4.3.9 Statistical Analysis 
All data were analyzed using Prism 7 (Graphpad Software Inc.). No statistical methods 
were used to compute sample size. Each data set was checked for normality and homogeneity of 
variance and unless otherwise stated data were analyzed using parametric statistical tests. In all 
cases, the significance threshold was set at p < 0.05. Values that were greater than two standard 
deviations from the mean were considered statistical outliers and were excluded from the data 
set. ANOVA’s were followed by post hoc tests as indicated. All values are presented as the 
mean±SEM. 
4.4 Results 
4.4.1 DA reconfigures the activity-dependence of LP Ih and IA 
LP phase depends, in part, upon a positive correlation between LP IA and Ih (Zhao and 
Golowasch 2012). When LP phase is disrupted by reducing LP IA, phase can recover over 
minutes, but only in the presence of tonic nM DA; and, tonic nM DA permits activity to regulate 
LP Ih (Rodgers, Fu et al. 2011, Krenz, Hooper et al. 2013, Krenz, Rodgers et al. 2015). We 
hypothesize that LP IA is regulated by activity in the presence and/or absence of DA, and that 
DA allows activity-dependent co-regulation of IA and Ih to maintain LP phase. We tested this 
hypothesis by examining if/how activity regulated LP IA in the presence and absence of tonic nM 
DA. 
LP shows spontaneous ~1Hz, ~20mV oscillations in membrane potential that traverse the 
~ -60 to -40mV range. There is a plateau of variable duration at the depolarized potential (Fig 
4.1A). This slow wave activity is generated in the somatodendritic compartment. Spiking activity 
is generated at the spike initiation zone on the axon/primary process. Spikes do not actively 
propagate into the somatodendritic compartment; rather, they passively spread and can be seen 
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riding on the depolarized plateau in somatic intracellular recordings (Fig 4.1A). Duty cycle, 
defined as plateau duration divided by cycle period, represents the fraction of the cycle during 
which LP is maximally depolarized. We previously demonstrated that changes in duty cycle can 
regulate LP Ih in the presence of tonic nM DA (Fig 4.1B). We used the same standard paradigm 
to investigate whether changes in slow wave activity affected LP IA in the presence and absence 
of tonic 5nM DA. LP spontaneous slow wave and spike activities were blocked with 10-7M 
TTX, and TEVC was used to implement a repetitive voltage step that mimicked slow waves (Fig 
4.1A).  
The experiment is diagrammed in Fig 4.1A. The preparation was dissected and 
continuously superfused with saline. The LP neuron was identified with electrophysiological 
recordings. At t=-10min LP plateau duration, cycle period, peak and nadir voltages were 
measured, and three voltage protocols were constructed for that particular neuron using 
Clampex. A 0%ΔDC protocol exactly mimicked LP plateau duration, cycle period, peak and 
nadir voltages. A +50%ΔDC protocol increased the duration of the depolarized step by 50% and 
decreased the time between steps to maintain a constant cycle period. A -100%ΔDC protocol 
abolished slow waves by holding LP at its resting potential in TTX (-59mV on average) with no 
voltage step applied. TTX was applied at t=-5min, and the voltage protocols were implemented 
as depicted. The percent change in the peak IA resulting from the +50%ΔDC and -100%ΔDC 
relative to 0%ΔDC voltage protocols was plotted (Fig 4.1C). The results demonstrated that in the 
absence of tonic 5nM DA, peak LP IA was regulated by slow wave activity in a manner very 
similar to that observed for LP Ih Gmax in the presence of DA. The -100%ΔDC protocol 
significantly increased the mean peak LP IA by 13 ± 2.2% while the +50%ΔDC protocol 
produced a significant 14 ± 3.3% decrease in the mean peak LP IA. 
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In order to test the effect of tonic 5nM DA, a separate series of experiments was 
performed exactly as described except that 5nM DA was added to the superfusate immediately 
after the first measure of LP IA (t=0). Previous work showed tonic 5nM DA did not obviously 
alter LP IA Gmax over the short term (Zhang, Rodgers et al. 2010, Rodgers, Krenz et al. 2011, 
Rodgers, Krenz et al. 2013). The addition of 5nM DA to the superfusate abolished slow wave 
activity-dependent changes in LP IA (Fig 4.1C). These data disproved our hypothesis. Even 
though changes in slow wave activity similarly regulated LP IA and Ih, tonic nM DA 
simultaneously disabled and enabled their respective activity-dependence. Thus, the two 
conductances would not be correlated in the presence of tonic nM DA alone (i.e. all modulatory 
input blocked with TTX and 5nM DA added to a constant superfusate). However, we have 
shown that addition of DA to an unblocked preparation (no TTX to block modulatory input) 
permitted phase recovery (Rodgers, Fu et al. 2011, Krenz, Rodgers et al. 2015). This suggests 
that slow wave activity may correlate LP IA and Ih under the appropriate modulatory conditions. 
4.4.2 Logic supporting link between SUMOylation and activity-dependent regulation 
of LP IA and Ih 
We previously demonstrated that tonic 5nM DA permitted bi-directional LP Ih activity-
dependence by eliciting two simultaneous PKA-dependent events that could be 
pharmacologically uncoupled (Krenz, Rodgers et al. 2015): event 1- a ~12% activity-independent 
increase in LP Ih Gmax, and event 2- a calcineurin-mediated decrease in LP Ih Gmax. Calcineurin is 
a Ca2+-calmodulin (CaM)-dependent phosphatase, and event 2 relied on Ca2+ entry through 
voltage-gated Ca2+ channels and Ca2+ release from stores, suggesting a Ca2+ induced Ca2+ release 
process. Bi-directional activity-dependence was achieved through the additive effects of events 1 
and 2. Since event 1 was activity-independent, it was constant in all three voltage protocols 
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(~12% increase in Ih Gmax). On the other hand, event 2 (Ca2+-dependent decrease in Ih Gmax) was 
minimal, maximal and intermediate during the -100%ΔDC, +50%ΔDC, and 0%ΔDC protocols, 
respectively. The addition of events 1 and 2 produced an increase and a decrease in LP Ih Gmax, 
respectively, during the -100%ΔDC and +50%ΔDC protocols relative to the 0%ΔDC protocol 
(Fig 4.1B). SUMOylation of mouse HCN channels, which mediate Ih, increased their surface 
expression and augmented Ih Gmax in human embryonic kidney (Hek) cells (Parker, Welch et al. 
2016). We therefore surmised that events 1 and 2 could correspond to an increase and decrease 
in HCN channel SUMOylation, respectively. Here we begin to test this hypothesis. 
4.4.3 HCN and Kv4 channels are SUMOylated in vivo 
To determine if lobster HCN and Kv4 channels, which respectively mediate Ih and IA, 
were SUMOylated in vivo, we performed immunoprecipitation (IP) experiments with lobster 
CNS protein lysates followed by western blotting. IP experiments were carried out using custom 
affinity-purified antibodies against the lobster HCN channel (anti-HCN), the lobster Kv4 channel 
(anti-ORF-J) and IgG (negative control). Western blots containing the resulting IP products were 
probed with a commercially available affinity-purified antibody against SUMO (anti-SUMO), 
and either anti-HCN (Fig 4.2A) or anti-ORF-J (Fig 4.2B). Both HCN and Kv4 channels appeared 
to be SUMOylated in vivo. The anti-HCN and anti-SUMO antibodies recognized multiple 
matching bands in the anti-HCN but not the IgG IP product. The bands were in the correct size 
range for post-translationally modified HCN channel alternately-spliced isoforms (Ouyang, 
Goeritz et al. 2007). The anti-ORF-J and anti-SUMO antibodies recognized a single, 
appropriately sized, matching band in the anti-ORF-J but not the IgG IP product. The anti-
SUMO antibody recognized additional bands not recognized by the channel antibodies in both 
81 
the anti-HCN and anti-ORF-J but not the IgG IP products. These may represent SUMOylated 
proteins that non-covalently interact with the channels. 
4.4.4 SUMOylation is necessary for activity-dependent changes in LP Ih and IA 
We next determined if Ih and IA were affected by anacardic acid, a cell permeable 
SUMOylation blocker (Fukuda, Ito et al. 2009). Either Ih or IA was measured, then 100µM 
anacardic acid was or was not added to the superfusate and a 1hr 0%ΔDC voltage protocol was 
applied followed by TEVC to re-measure the current. No significant changes were observed in 
the absence of anacardic acid (Wilcoxon test, p>0.1, n=3 each for Ih and IA). In the presence of 
anacardic acid, the mean LP Ih Gmax significantly decreased by 14±4.5% and the mean peak IA 
significantly increased by 9.7±2.8% (Fig 4.3A). These data suggest that dynamic SUMOylation 
contributes to the maintenance of LP Ih and IA. We asked if anacardic acid could also block 
activity-dependence. Experiments similar to those diagrammed in Fig 4.1A were repeated except 
that anacardic acid was added to the superfusate for 1hr prior to the addition of TTX. The data 
indicated that blocking SUMOylation with anacardic acid abolished the DA-enabled activity-
dependence of LP Ih (Fig 4.3B) and the activity-dependence of LP IA in the absence of DA (Fig 
4.3C). These data indicated that SUMOylation was necessary for activity-dependent changes in 
LP Ih and IA. 
4.4.5 Enhanced SUMO availability converts bi-directional into one-way DA-enabled 
LP Ih activity-dependence 
If dynamic SUMOylation regulates LP Ih Gmax, then enhancing SUMOylation should 
have the opposite effect of blocking SUMOylation. Furthermore, if DA enables activity-
dependent SUMOylation, then enhancing SUMOylation should disrupt the permissive effect of 
tonic 5nM DA. We tested these hypotheses. The enzyme Ubc9 covalently links SUMO to a 
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lysine on a target protein (Desterro, Thomson et al. 1997). Ubc9 can either recognize a SUMO 
consensus sequence on a target protein and conjugate SUMO to the consensus sequence, or Ubc9 
can be directed to a target by an E3 ligase or a SUMO Interaction Motif (SIM), in which case 
SUMOylation does not occur at a consensus sequence (Flotho and Melchior 2013). 
Approximately 63% of all SUMOylation occurs at consensus sequences, though this can change 
in a state-dependent manner (Hendriks and Vertegaal 2016). Simply increasing the concentration 
of SUMO and/or Ubc9 can enhance SUMOylation at consensus sequences (Dai, Kolic et al. 
2009). We used this method to increase mouse HCN2 channel SUMOylation at an identified 
consensus sequence in a heterologous expression system, which resulted in augmentation of 
channel surface expression and Ih Gmax (Parker, Welch et al. 2016). Here we used the same logic 
to increase SUMOylation at consensus sequences in the LP neuron to test if/how this affected Ih 
Gmax and activity-dependent regulation of Ih.  
We cloned lobster SUMO cDNA (GenBank accession: MF770707) and used standard 
techniques to generate an N-terminal Tat-tagged SUMO peptide (Supp Fig 4.1). The activated 
form of the peptide that ends in a C-terminal di-glycine was created; it required no further 
proteolytic processing before addition to a target (See Supp Fig 4.1)(Mukhopadhyay and Dasso 
2007). Peptides tagged with an HIV-Tat sequence are rapidly taken up by cells (Fawell, Seery et 
al. 1994). After confirming that the activated Tat-SUMO peptide was successfully taken up by 
crustacean neurons (Supp Fig 4.1), we tested its effect on LP Ih Gmax.  
The three standard voltage protocols were used in experiments as diagramed in Fig 4.4A. 
A 30min wash-in of activated Tat-SUMO had the opposite effect of blocking SUMOylation; it 
produced a stable and significant 11±1.5% increase in the mean LP Ih Gmax in the absence of DA 
(Fig 4.4B) as opposed to the ~14% decrease produced by anacardic acid blockade (Fig 4.3A). 
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The mean τ for the increase was 7.1min. The same result was obtained when the Tat-SUMO 
peptide was applied during a 30min -100%ΔDC or 0%ΔDC voltage protocol (Fig 4.4B), 
indicating that an activity-independent process transduced enhanced SUMO availability into an 
increase in LP Ih Gmax. Note that DA-enabled event 1 produced an activity-independent, ~12% 
increase in LP Ih with a time constant of 9.9min (Krenz, Rodgers et al. 2015). Thus, enhancing 
SUMO availability in LP mimicked DA-enabled event 1. Enhanced SUMO availability also 
occluded DA-enabled event 1. A 30min activated Tat-SUMO wash-in was followed by 
application of the -100%ΔDC protocol in the presence or absence of 5nM DA. The data showed 
that application of the -100%ΔDC protocol in the presence of DA produced no further change in 
LP Ih (Fig 4.4C).  
Enhanced activated SUMO availability mimics and occludes DA-enabled event 1. An 
increase in activated SUMO ultimately translates into enhanced target protein SUMOylation. 
Lobster HCN channels are targets of SUMOylation (Fig 4.2A). HCN channel SUMOylation can 
augment HCN channel surface expression (Parker, Welch et al. 2016). Together, these data 
suggest that DA-enabled event 1 may represent enhanced HCN channel SUMOylation. 
Using the same experimental protocol (Fig 4.4A), we also examined whether or not 
enhanced SUMO availability blocked the DA-enabled, calcineurin-mediated, activity-dependent 
decrease in LP Ih (event 2). Enhanced SUMO availability did not obviously alter event 2 (Fig 
4.4C). In the presence of tonic 5nM DA and limitless activated SUMO, the +50%ΔDC protocol 
still produced a significant average 9.5±1.8% decrease in LP Ih Gmax. This decrease was not 
observed in the absence of tonic DA. Thus, enhanced SUMO availability did not block the 
calcineurin-mediated decrease in LP Ih, and event 2 still required DA’s permissive effect. 
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4.4.6 DA blocks the effect of enhanced SUMO availability on LP IA 
We previously demonstrated that increasing Kv4.2 channel SUMOylation at an identified 
consensus sequence significantly decreased IA Gmax in Hek cells (Welch, Forster et al.). Note that 
in Hek cells, increased channel SUMOylation drove Gmax in opposite directions for IA and Ih. In 
order to determine the effect of increased activated SUMO availability on LP IA, experiments 
using the three standard voltage protocols were performed as diagramed in Figure 4.5A. In the 
absence of Tat-SUMO wash-in, LP peak IA was stable during a 30min 0%ΔDC voltage protocol 
(Fig 4.5B). Enhancing the availability of activated SUMO, while keeping duty cycle constant, 
mimicked and occluded the decrease in peak IA normally elicited by an increasing LP duty cycle. 
A 30min wash-in of activated Tat-SUMO during a 0%ΔDC voltage protocol produced a 
significant 10.1±1.4% reduction in the mean peak IA that was stable by 30min (Fig 4.5B). This 
was opposite to the ~10% increase produced by blocking SUMOylation with anacardic acid (Fig 
4.3A). Additionally, there was no further change in LP peak IA when the +50%ΔDC protocol 
was implemented after the 30min wash-in of activated Tat-SUMO (Fig 4.5C). On the other hand, 
decreasing duty cycle by implementing the -100%ΔDC protocol after a 30min activated Tat-
SUMO wash-in produced a slightly lower, but still significant, mean 7.6±2.3% increase in peak 
IA (Fig 4.5C). Together these data suggest that bi-directional activity-dependent regulation of LP 
IA may be similar to Ih in that it involves two events: event 1- An activity-independent process 
that increases SUMOylation and event 2- An activity-dependent process that may reduce 
SUMOylation. 
If enhanced SUMOylation mediates the decrease in LP IA elicited by an increased duty 
cycle, and tonic 5nM DA can block the activity-dependent decrease in LP IA (Fig 4.1C), then DA 
should block the effect of enhanced activated SUMO availability. In a separate series of 
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experiments, 5nM DA was added to the superfusate 10min prior to the start of the 30min Tat-
SUMO wash-in; otherwise, the experimental protocol was identical. Tonic 5nM DA completely 
blocked the decrease in LP IA due to enhanced activated SUMO availability (Fig 4.5B). This 
result is consistent with our hypothesis that DA reconfigures the targets of the SUMOylation 
machinery to remove activity-dependence from one conductance and bestow it on another. 
4.5 Discussion 
Neurons exhibit several types of activity-dependent plasticity that act on synaptic 
strength and dynamics (Blitz, Foster et al. 2004, Turrigiano 2011, Daur, Bryan et al. 2012), 
intrinsic properties (Rodgers, Fu et al. 2011, Krenz, Hooper et al. 2013, Krenz, Rodgers et al. 
2015) and even electrical coupling (Lane, Samarth et al. 2016); but, it is unclear how the 
plurality of mechanisms is organized to simultaneously effect both change and stability, and how 
this organization is restructured with changes in state. We investigated one mechanism of HIM 
that promotes stability by maintaining a positive correlation between LP IA and Ih to preserve 
neuronal activity phase. Our study showed that activity-dependent SUMOylation specified a 
positive correlation between LP IA and Ih, but that modulatory tone played a permissive role in 
implementing that correlation. Fig 4.6 summarizes SUMOylation-mediated, activity-dependent 
regulation of the two conductances. Alterations in LP duty cycle drove changes in SUMOylation 
that modified current amplitudes (Fig 4.6). The activity-dependent changes in SUMOylation 
were opposite for the two conductances, but the effect of SUMOylation on current amplitudes 
was also opposite; thus, a positive correlation was specified. We initially hypothesized that DA 
alone permitted the positive correlation between LP IA and Ih; however, our data proved the 
hypothesis wrong. Tonic 5nM DA disabled activity-dependent regulation of LP IA, and thereby 
prevented the correlation. The data suggest that the correlation will only be observed when LP is 
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bathed by the appropriate modulatory mélange that allows the simultaneous activity-dependent 
regulation of both conductances. 
We previously demonstrated that DA permitted activity-dependent regulation of LP Ih by 
enabling two distinguishable events (Krenz, Rodgers et al. 2015). Event 1 produced an activity-
independent increase in Ih Gmax. Here we showed that event 1 was mimicked and occluded by 
increasing the availability of activated SUMO in the LP neuron. Furthermore, event 1 could be 
blocked by globally inhibiting LP SUMOylation with anacardic acid. Previous experimentation 
on Hek cells overexpressing mouse HCN2 channels showed that increasing SUMO availability 
enhanced SUMOylation of the HCN channel at a specific consensus sequence, and this resulted 
in increased surface expression and augmentation of Ih Gmax (Parker, Welch et al. 2016). Western 
blot experiments indicated that lobster HCN channels were SUMOylated in vivo. The most 
parsimonious interpretation of these data is that DA-enabled event 1 produces an increase in LP 
Ih Gmax by enhancing HCN channel SUMOylation and surface expression. We previously 
demonstrated that event 2 produced an activity-dependent, CaM-calcineurin-mediated decrease 
in Ih Gmax (Krenz, Rodgers et al. 2015). Here we demonstrated that globally blocking LP 
SUMOylation, mimicked and occluded the decrease associated with event 2. One of the most 
straight forward interpretations is that event 2 represents a DA-enabled, Ca2+-dependent 
reduction in HCN channel SUMOylation and surface expression. In the simplest case, the 
combination of DA-enabled events 1 and 2 help to bi-directionally regulate the SUMOylation 
profile and surface expression of HCN channels in an activity-dependent fashion. 
Activity-dependent regulation of LP IA also appeared to depend on two separable events 
that may regulate Kv4 channel SUMOylation. Western blot experiments showed that lobster Kv4 
channels, which mediate LP IA (Baro, Levini et al. 1997, Baro, Ayali et al. 2000), were 
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SUMOylated in vivo. Blocking SUMOylation mimicked and occluded the activity-dependent 
increase in LP peak IA that was observed during the -100%ΔDC protocol. Enhanced activated 
SUMO availability produced an activity-independent decrease in LP IA that mimicked and 
occluded the reduction observed during the +50%ΔDC voltage protocol. Blocking SUMOylation 
prevented the activity-dependent decrease observed during the +50%ΔDC voltage protocol. In 
another study on Hek cells, we showed that increased SUMOylation reduced IA mediated by 
mouse Kv4.2 channels, and that the decrease was blocked by mutating a specific SUMO 
consensus sequence on Kv4.2 (Welch, Forster et al.). It is not yet clear whether the surface 
expression and/or biophysical properties of mouse Kv4.2 channels were altered, as 
SUMOylation can affect both characteristics (Henley, Craig et al. 2014). In the simplest case, the 
data suggest that an activity-independent process (event 1) increases LP Kv4 channel 
SUMOyaltion to reduce IA, while an activity-dependent process (event 2) decreases LP Kv4 
channel SUMOylation to augment IA. Tonic 5nM DA blocked events 1 and 2. 
DA could permit (Ih) and prevent (IA) activity-independent event 1 by reconfiguring the 
targets of the SUMOylation machinery. The literature suggests that this could be accomplished 
by alterations in target protein phosphorylation states (Hietakangas, Anckar et al. 2006, 
Konopacki, Jaafari et al. 2011, Loriol, Casse et al. 2014, Dustrude, Moutal et al. 2016). Target 
phosphorylation can either promote or prevent target SUMOylation. For example, one target 
protein, cytosolic axonal collapsin response mediator protein 2 (CRMP2), which enhances the 
surface expression of NaV1.7 channels, has phosphorylation sites with opposing effects 
(Dustrude, Wilson et al. 2013, Dustrude, Moutal et al. 2016). Phosphorylation at S522 by Cdk5 
promoted CRMP2 SUMOylation. Conversely, phosphorylation at Y32 by Fyn inhibited CRMP2 
SUMOylation. Ultimately, the phosphorylation state of CRMP2 helped determine its 
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SUMOylation state and thereby NaV1.7 surface expression. These findings provide a simple 
potential mechanism for how modulatory tone could (re)configure the targets of the 
SUMOylation machinery. 
It is not clear how DA permits/prevents activity-dependent event 2. Activity can regulate 
SUMOylation in a cell specific manner. SUMOylation was globally increased by either KCl 
depolarization in SHSY5Y cells and hippocampal neurons (Lu, Liu et al. 2009, Lee, Dale et al. 
2014) or TTX activity blockade in cortical neurons (Craig, Jaafari et al. 2012). Activity-
dependent changes in SUMOylation profiles are often mediated by altering the abundance, 
location and/or activity of the SUMOylation machinery. The SUMO conjugating enzyme, Ubc9, 
is increased both pre- and post-synaptically in response to LTP (Feligioni, Nishimune et al. 2009, 
Jaafari, Konopacki et al. 2013). In hippocampal neurons, KCl depolarization localizes Ubc9 to 
presynaptic but not postsynaptic densities (Loriol, Khayachi et al. 2013). Increased neuronal 
activity and activation of mGluR5 leads to diffusional trapping of Ubc9 in hippocampal dendritic 
spines (Loriol, Casse et al. 2014). The N-terminus of the SENP family of SUMO deconjugating 
enzymes controls their abundance, localization and activity (Hickey, Wilson et al. 2012, Nayak 
and Muller 2014, Mendes, Grou et al. 2016). SENP was decreased by TTX activity blockade in 
cortical neurons (Craig, Jaafari et al. 2012). In hippocampal neurons, KCl depolarization led to a 
transient presynaptic redistribution of SENP (Loriol, Khayachi et al. 2013). Phosphorylation is 
known to regulate both SUMO conjugating and deconjugating enzymes (Baldwin, Julius et al. 
2009, Hickey, Wilson et al. 2012, Su, Yang et al. 2012, Lin, Liu et al. 2016), and it is reasonable 
to assume that Ca2+-dependent kinases and phosphatases could alter Ubc9 and/or SENP activity, 
abundance and localization in the LP neuron to produce activity-dependent deSUMOylation. DA 
could influence this pathway through any number of mechanisms. 
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Dynamic SUMOylation appears to contribute to baseline LP IA and Ih. Blocking 
SUMOylation over the course of 1hr, in the absence of DA while keeping activity constant, 
produced a significant decrease in LP Ih Gmax and a significant increase in LP peak IA. This 
suggests that ongoing processes of SUMOylation and deSUMOylation dynamically tune LP 
ionic conductances and that SUMOylation states may reflect the continuous integration of 
chemical signals and electrical activity. Identifying ion channel SUMOylation profiles, their 
effects and their regulation could provide insight into how activity correlates multiple 
conductances and how modulatory tone permits or prevents those correlations. 
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Figure 4.1 Tonic 5nM DA reconfigures the activity-dependence of LP IA and Ih 
(A) Experimental Protocol for examining activity-dependence of LP IA. The diagram depicts LP 
slow wave activity at t=-10min. Plateau duration (250ms), peak (-40mV) and nadir (-60mV) 
voltages, and cycle period (850ms) were measured and used to create the three diagrammed 
voltage protocols. Note voltage protocols were always specifically designed for each cell based 
on measurements from that cell. The protocols were used in standard experiments as diagramed. 
At t=-5min, TTX was bath applied and the 0%∆DC protocol was initiated. At t0 the current was 
measured (red asterisk) and one of the two indicated series of voltage protocols was implemented 
in the presence or absence of 5nM DA. The current was measured at the end of each protocol as 
indicated by the red asterisks. The order of the voltage protocols was varied between 
experiments as shown in the two timelines. (B) LP Ih activity-dependence. Data were taken from 
(Krenz, Rodgers et al. 2015). The plot represents the percent change in LP Ih Gmax resulting from 
a 10min change in duty cycle in the presence or absence of 5nM DA, as indicated. Green 
asterisks represent a significant difference within a treatment group using paired t-tests, p<0.05. 
Black asterisks indicate significant differences using a One-way ANOVA with Bonferroni’s 
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multiple comparisons post hoc tests to compare selected pairs, as indicated, F(3,23)= 9.146; 
p=0.0004. (C) LP IA activity-dependence. The plot represents the percent change in LP peak IA 
following a 20min change in duty cycle [(t60÷t40 or t20÷t0)-1x100] using the indicated voltage 
protocol in the presence or absence of 5nM DA. Green asterisks, significant difference within a 
treatment group using paired t-tests (t0 vs t20, or t40 vs t60), p≤0.05. Black asterisks, significant 
differences using a One-way ANOVA with Bonferroni’s multiple comparisons post hoc tests to 
compare selected pairs, as indicated, F(3,31)= 8.512; p<0.0003 
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Figure 4.2 Panulirus interruptus HCN and Kv4 channels are SUMOylated in vivo 
Lysates prepared from lobster nervous system tissue were used in immunoprecipitation (IP) 
experiments with antibodies against the lobster HCN channel (anti-HCN) (A), the lobster Kv4 
channel (anti-ORF-J) (B) or IgG (A and B, negative control). Western blots (WB) containing the 
IP products were probed with anti-HCN, anti-ORF-J, or mouse anti-SUMO as indicated. 
Immunoprecipitation experiments were repeated with at least three animals for each channel and 
representative results are shown. The SUMO modified HCN and Kv4 channels have been 
indicated. Asterisks indicate SUMOylated proteins that potentially interact with the 
immunoprecipitated channel. Unmarked bands present in the IgG IP represent noise 
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Figure 4.3 SUMOylation is necessary for the maintenance and activity-dependence of LP 
Ih and IA 
(A) SUMOylation contributes to the maintenance of LP Ih and IA. Either Ih or IA was measured at 
t=0, anacardic acid (AA) was added to the superfusate and the 0%ΔDC protocol was 
implemented for 1hr after which the current was re-measured. The mean percent change in each 
current is plotted [(t60÷t0)-1x100]. Asterisk, paired t-test p<0.05, n=6 each. (B) The effect of AA 
on activity-dependent changes in LP Ih. The experiment was similar to that depicted in Fig 4.1A, 
except that AA was added to the superfusate 1hr prior to TTX. Upper panel: Current traces from 
two representative experiments are shown. Two current traces elicited by a hyperpolarizing 
testpulse to -120mV during a single experiment were overlaid. The two traces from the same cell 
represent LP Ih immediately after a 20min -100%∆DC protocol (purple) or a +50%∆DC protocol 
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(cyan); scale bars, 10nA and 1s. Lower panel: Plot of the mean percent change in LP Ih Gmax 
following a 20min change in duty cycle in the presence of AA. Experiments lacking AA are 
shown for comparison. Green asterisks significant difference within a treatment group using a 
paired t-test, p<0.05. Black asterisk significant difference between the four treatment groups 
using a One-way ANOVA with Bonferroni’s multiple comparisons post hoc tests to compare 
selected pairs, as indicated, F(3,17)= 7.814; p=0.0017. NS, no significant difference (C) The 
effect of AA on activity-dependent changes in LP IA. The experiment was similar to that 
depicted in Fig 4.1A, except that AA was added to the superfusate 1hr prior to TTX. Upper 
panel: Current traces from two representative experiments are shown. Two current traces elicited 
by a depolarizing testpulse to +40mV during a single experiment were overlaid. The two traces 
from the same cell represent LP IA immediately after a 20min -100%∆DC protocol (purple) or a 
+50%∆DC protocol (cyan); scale bars, 100nA and 40ms. Lower panel: Plot of the mean percent 
change in peak LP IA following a 20min change in duty cycle in the presence of AA. 
Experiments lacking AA were shown for comparison. Green asterisks, significant difference 
within a treatment group using a paired t-test, p<0.05. Black asterisks, significant differences 
using a One-way ANOVA with Bonferroni’s multiple comparisons post hoc tests to compare 
selected pairs, as indicated, F(3,19)= 11.87; p=0.0001. NS, no significant difference 
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Figure 4.4 Enhancing SUMO availability converts DA-enabled, LP Ih activity-
dependence from bi-directional to uni-directional 
(A) Experimental Protocol. The diagram generally depicts the experiments; red asterisks indicate 
points where LP Ih was measured; the order of the -100%ΔDC and +50%ΔDC voltage protocols 
was varied between experiments; some experiments ended at t30 or t50. (B) Tat-SUMO wash-in 
increases LP Ih Gmax. Activated Tat-SUMO was added to the superfusate and LP Ih was measured 
every 10min for 30min. The percent change in LP Ih Gmax at t10, t20, and t30 relative to t0 is 
plotted. Asterisks, significantly different using Repeated Measures ANOVAs with Dunnett’s 
post-hoc tests that compared each data point to t0. 0%∆DC: F(4,12)= 21.03; p=0.0026, n=5; -
100%∆DC: F(5,15)=23.01; p=0.0002, n=6. (C) Enhancing SUMO availability occludes the DA-
enabled, activity-dependent increase in LP Ih Gmax but does not alter the DA-enabled activity-
dependent decrease. After a 30min activated Tat-SUMO wash-in, DA was or was not added to 
the superfusate containing activated Tat-SUMO, and the indicated voltage protocols were 
applied. The percent change in LP Ih Gmax [(t50÷t30 or t90÷t30)-1x100] in the presence and absence 
of DA was plotted. Green Asterisks, significant change within a treatment group (t50 vs t30 or t90 
vs t30), paired t-test p<0.01. Black asterisk, significant difference using a One-way ANOVA with 
Bonferroni’s multiple comparisons post hoc tests to compare selected pairs, as indicated, 
F(3,16)= 7.101; p<0.003 
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Figure 4.5 Enhancing SUMO availability converts LP IA activity-dependence from bi-
directional to uni-directional 
(A) Experimental Protocol. The diagram generally depicts the experiments; red asterisks indicate 
points where LP IA was measured; the order of the -100%ΔDC and +50%ΔDC voltage protocols 
was varied between experiments; some experiments ended at t30 or t50. (B) Tat-SUMO wash-in 
decreases LP peak IA. Percent change in LP peak IA at t10, t20, and t30 relative to t0. Asterisks, 
significantly different using Repeated Measures ANOVA with Dunnett’s post-hoc that compared 
each data point to t0; 0%∆DC: F(4,12)=0.1682; p=0.7381, n=5; 0%∆DC + Tat-SUMO: 
F(10,30)= 13.65; p=0.0011, n=11; 0%∆DC + Tat-SUMO + DA: F(5,15)= 0.3438; p=0.7086, 
n=6. (C) Enhancing SUMO availability occludes the activity-dependent decrease in LP peak IA. 
Plot of the percent change in LP peak IA [(t50÷t30 or t90÷t30)-1x100] after the indicated change in 
duty cycle. Green Asterisks, significant change within a treatment group (t50 vs t30 or t90 vs t30), 
paired t-test p<0.05. Black Asterisks, significant change between groups, student t-test p<0.05 
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Figure 4.6 Summary of SUMO-mediated, activity-dependent regulation of LP Ih and IA 
The diagram represents a data-driven 3-dimensional sketch of how current amplitude (y-axis) 
and ion channel SUMOylation (z-axis) change according to LP duty cycle (x-axis). The blue bar 
represents LP Ih in the presence of 5nM DA and the green bar represents LP IA in the absence of 
5nM DA. Activity-dependent changes in current amplitude were similar for both currents: 
Increasing duty cycle reduced the current. Activity-dependent changes in SUMOylation were 
opposite for target proteins associated with IA and Ih: Increasing duty cycle increased vs. 
decreased SUMOylation associated with LP IA vs. Ih, respectively. SUMOylation of the target 
proteins produced opposite effects on current amplitude: increasing SUMOylation decreased LP 
IA and increased LP Ih. We hypothesize that the ion channels mediating LP IA (Kv4) and Ih 
(HCN) were the targets of activity-dependent SUMOylation, but this was not shown directly, and 
we cannot rule out the idea that the changes in SUMOylation evoked in this study may occur on 
unknown targets 
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Figure 4.7 Supplemental 1 - Validation for Tat-SUMO experiments 
(A) Comparison of lobster SUMO with each of the mouse SUMOs. SUMO was cloned from 
spiny lobster nervous system tissue (GenBank accession: MF770707). Aligning the amino acid 
sequence showed that Panulirus SUMO shares ~47% identity with mouse SUMO1(Genbank 
accession: P63166) and ~67% identity with mouse SUMO2 and 3 (Genbank accession: P61957 
and Q9Z172 respectively).  Highlighted areas represent regions of conservation. Arrowhead 
indicates the site where SUMO is cleaved to generate the mature peptide ending in di-glycine. 
(B) Tat-HA-His-SUMO Construct. Active Panulirus SUMO (C-terminal di-glycine) was 
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subcloned into a Tat-HA-His vector, which was then used to synthesize a Tat-tagged Panulirus 
SUMO peptide. (C) Western blot of recovered Tat-SUMO peptide. Tat-SUMO peptide was 
purified using Ni-NTA agarose resin and was eluted from the resin with incrementally increasing 
concentrations of imidazole (100mM, 250mM, 500mM, 1M). Purity of Tat-SUMO peptide was 
confirmed by western blotting. Eluted fractions were probed with a rabbit polyclonal anti-mouse 
SUMO1 antibody (Santa Cruz Biotechnology, sc-9060; used at 1:4000). Strong band at ~25kDa 
in 100mM and 250mM fractions represents Tat-SUMO peptide. Note that this experiment also 
validates that the mouse anti-SUMO 1 antibody can recognize the lobster peptide. (D) Tat-
SUMO is efficiently taken up by live cells in the STG. Tat-SUMO uptake into STG cells was 
tested by bath applying varied concentrations of the peptide to the STG (0nM, 10nM, 100nM, 
and 1µM). The preparations were then fixed and immunostained with a validated, commercially 
available anti-Tat antibody (Abcam, ab63957, used at 1:200) as previously described (Baro, 
Ayali et al. 2000). Tat-SUMO immunostaining was not visible in the absence of bath applied 
Tat-SUMO (0nM). When Tat-SUMO was bath applied, immunostaining was clearly visible in 
the nucleus and cytoplasm of the neurons as well as in the surrounding glial cells. Tat-SUMO 
uptake appeared to increase in a concentration-dependent manner; 100nM appeared to be optimal 
with no detectable improvement at a higher concentration. scale bar, 50µm 
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Figure 4.8 Supplemental 2 - Validation of antibodies used for immunoprecipitation and 
western blotting 
(A) An antibody against mouse SUMO 1 recognized lobster SUMO. The lobster and 
mouse SUMO proteins are highly conserved and a mouse anti-SUMO 1 antibody is capable of 
recognizing a purified recombinant lobster SUMO peptide (Supp Fig 4.1). A western blot 
containing lobster nervous system lysate was probed with the same rabbit polyclonal anti-
SUMO1 antibody. The antibody successfully recognized the ~10kDa free SUMO (arrow) in 
addition to other higher molecular weight bands representing other SUMOylated proteins. (B) 
The anti-HCN antibody recognized lobster HCN channels expressed in Hek cells. The lobster 
HCN channel was subcloned into a GFP expression vector and a GFP-HCN fusion protein was 
stably expressed in Hek cells using previously described methods (Parker, Welch et al. 2016). 
The GFP-HCN channel was isolated from Hek cell lysates in IP experiments using an antibody 
against GFP. Western blots containing the IP product were probed with anti-HCN (see materials 
and methods). The strong signal visible at ~110kDa represents the channel (arrow). As a 
negative control, the IP-western blot experiment was repeated with parental Hek cells that did 
not express the GFP-HCN construct. (C) The anti-ORF-J antibody recognized the lobster Kv4 
channel in lobster nervous system lysates. Western blots containing lobster nervous system 
protein lysates were probed with anti-ORF-J or anti-shal, a previously validated antibody against 
the lobster Kv4 channel (Baro, Ayali et al. 2000). Both antibodies recognized the same ~75kDa 
band (arrow) 
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5 GENERAL DISCUSSION 
5.1 SUMO regulation of neuronal homeostasis 
The work presented here demonstrates that within a single neuron, SUMO can 
orchestrate the activity-dependent regulation of multiple ionic conductances. This speaks to a 
much larger potential role for SUMOylation in coregulating activity-dependent mechanisms 
involved in the maintenance of neuronal homeostasis. Recent studies have found linked changes 
in neuronal SUMOylation with changes in neuronal excitability. In hippocampal neurons for 
example, including SUMO in a patch pipette increases neuronal excitability, with the inverse 
being true when the deSUMOylating enzyme, SENP, was included in the pipette (Plant, Dowdell 
et al. 2011). Altering neuronal excitability can also impact the SUMOylation machinery and 
consequently, SUMOylation of target proteins. Suppression of activity with TTX results in a 
global decrease in SENP and therefore an increase in SUMOylated proteins (Craig, Jaafari et al. 
2012). Depolarizing hippocampal neurons with KCl reorganizes the SUMOylation machinery 
and SUMOylated proteins at pre- and postsynaptic sites (Loriol, Khayachi et al. 2013). With 
global changes in SUMOylation affecting neuronal excitably, and SUMOylation being under the 
influence of changes in neuronal excitability it is not a stretch to infer that SUMO may be 
important for some types of activity-dependent regulation. Our work further supports this idea by 
showing that SUMOylation mediates the correlated activity-dependent regulation of two ionic 
conductances whose coregulation is known to be important for homeostasis of network activity.  
This study has shown that under the appropriate modulatory tone, SUMO can mediate 
activity-dependent regulation of two ionic conductances within a single neuron. There have been 
many studies examining what SUMO is doing in hippocampal neurons, and when assembled 
they illustrate a complex system of regulation. For example, SUMO regulates multiple glutamate 
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receptors in distinct ways in hippocampal neurons. SUMOylation of the metabotropic glutamate 
receptor subunit, mGluR7, stabilizes the receptor in the cell membrane (Choi, Park et al. 2016). 
The ionotropic glutamate receptor subunit, GluK2, is SUMOylated following phosphorylation of 
the receptor and results in increased internalization of GluK2 containing receptors (Chamberlain, 
Gonzalez-Gonzalez et al. 2012). Kainate binding promotes SUMOylation of GluR6 containing 
receptors and their subsequent internalization (Martin, Nishimune et al. 2007). Specific K+ 
channels were also identified as SUMO substrates in hippocampal neurons. For example, 
SUMOylation of the Kv2.1 channel positively shifts its voltage of half activation (Plant, Dowdell 
et al. 2011), and SUMOylation of the Kv7 channel diminishes the M current leading to 
hyperexcitability (Qi, Wang et al. 2014). Direct SUMOylation of each of these channels and 
receptor subunits and all of the diverse outcomes are occurring in a single neuronal cell type. Is 
SUMO simultaneously regulating all of these processes? The evidence presented here and the 
work of other investigators suggest that there may be mechanisms, like tonic DA modulation and 
phosphorylation, which can promote or prevent SUMO regulation of specific targets within a 
single cell (Dustrude, Wilson et al. 2013, Dustrude, Moutal et al. 2016). 
5.2 The function of tonic DA 
DA can be present in two functionally distinct concentrations (tonic and phasic). Phasic 
DA corresponds to a transient increase in DA concentrations (µM-mM) resulting from burst 
firing of dopaminergic neurons. Phasic DA functions to encode reward signals and can promote 
the later phase of plasticity in the prefrontal cortex, hippocampus, and striatum (Frey, Matthies et 
al. 1991, Grace 1991, Gurden, Tassin et al. 1999, Gurden, Takita et al. 2000, Reynolds, Hyland 
et al. 2001, Floresco, West et al. 2003, Huang, Simpson et al. 2004). Tonic DA refers to low 
steady-state concentrations of DA (nM) produced by the slow single spike activity of DA 
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neurons (Grace 1991, Keefe, Zigmond et al. 1993, Goto, Otani et al. 2007). Although less is 
known about the function of tonic DA, the consensus is that dopaminergic tone stabilizes neural 
network activity or maintains a specific neuronal activity state (Durstewitz, Seamans et al. 2000, 
Durstewitz, Seamans et al. 2000, Durstewitz and Seamans 2002, Bilder, Volavka et al. 2004, 
Matsuda, Marzo et al. 2006, Sikstrom and Soderlund 2007, Kroener, Chandler et al. 2009). Our 
work has begun to characterize the mechanisms through which tonic DA can act to stabilize 
neuronal activity states. 
5.2.1 Tonic spiking of DA neurons 
One important question to address first is, why do DA neurons fire tonically? Is it solely 
to maintain a specific level of extracellular dopaminergic tone, or is there more to the story? DA 
neurons fire tonically due to the presence of pacemaker channels (Grace and Bunney 1983), and 
this firing can be up and down-regulated based on afferent glutamatergic or GABAergic input 
(Grace and Bunney 1984, van Zessen, Phillips et al. 2012, Chang and Grace 2014). Within a 
given population of DA neurons, only a fraction is tonically active. Tonic spiking of DA neurons 
doesn’t just establish the nM levels of extracellular DA, but it provides a pool of neurons that can 
respond to phasic stimulation (Floresco, West et al. 2003, Lodge and Grace 2006, Belujon and 
Grace 2015, Grace 2016). Only DA neurons that are tonically active can respond to a stimulus 
with phasic bursting activity. Therefore, increasing or decreasing the number of tonically firing 
DA neurons will up or downregulate, the magnitude of the phasic response. This means that the 
tonic activity of DA neurons themselves functions to modulate the extent of the system’s phasic 
response. Therefore, neurons providing afferent inputs on DA neurons (ventral pallidum, 
pedunculopontine tegmental nucleus) can contextualize phasic stimulation by modulating the 
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number of tonically active neurons (Blaha, Yang et al. 1997, Lokwan, Overton et al. 1999, 
Floresco, Todd et al. 2001, Lodge and Grace 2006). 
5.2.2 Dopaminergic tone stabilizes neuronal activity states 
The stabilizing effect of tonic DA is thought to be mediated by the nM levels of DA 
present in the extracellular space rather than the tonic spiking activity of the DA neurons 
themselves. There are two different schools of thought on how tonic nM levels of DA can 
stabilize neuronal activity states, and it is likely that both mechanisms exist in vivo, either 
simultaneously or under contextually different circumstances. The first model suggests that tonic 
DA acts through either autoreceptors or desensitization of DA receptors to “set the gain” for the 
phasic response, thus maintaining stable neuronal activity (Belujon and Grace 2015, Grace 
2016). There are multiple theories about how this function is accomplished. Some investigators 
have said that tonic DA can set the threshold needed for phasic activity to alter an activity state. 
This would permit the maintenance of an activity state while still allowing a degree of flexibility 
if the phasic response can exceed that threshold (Durstewitz, Seamans et al. 2000, Durstewitz, 
Seamans et al. 2000, Durstewitz and Seamans 2002, Bilder, Volavka et al. 2004). Other 
investigators have demonstrated that tonic DA acting on autoreceptors can determine the 
magnitude of the phasic response. When tonic DA levels are enhanced the magnitude of phasic 
release is reduced, and conversely, a decrease in dopaminergic tone will enhance phasic release 
(Grace 2000, Floresco, West et al. 2003, Bilder, Volavka et al. 2004, Sikstrom and Soderlund 
2007). Tonic DA levels have also been shown to have a desensitizing effect on DA receptors, 
with agonist binding leading to internalization of DA receptors (Grace 1991, Grace 2000). 
However, it is worth noting that different responses have been observed in heterologous 
expression systems versus slice cultures. Even between heterologous expression systems, the 
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mechanisms mediating DA receptor internalization appear to differ in some respects (Ito, Haga et 
al. 1999, Kim, Valenzano et al. 2001, Celver, Sharma et al. 2013, Robinson, Bunzow et al. 
2017).  
The second prevailing theory proposes that tonic DA, acting at high-affinity DA 
receptors, stabilizes neuronal activity by regulating ionic conductances and certain types of 
plasticity. In the crustacean STG, many studies have shown that conductance correlations 
maintain specific neuronal activity features (Temporal, Desai et al. 2012, Zhao and Golowasch 
2012, O'Leary, Williams et al. 2013, Temporal, Lett et al. 2014, Marder, Goeritz et al. 2015). 
Specifically, DA has been shown to play an important role in the maintenance of conductance 
correlations (Khorkova and Golowasch 2007, Krenz, Parker et al. 2015). In LP, the correlation of 
IA and Ih is important to maintain LP timing within the circuit (MacLean, Zhang et al. 2003). 
When the ratio of IA to Ih is disrupted, LP activity phase is altered and in the presence but not the 
absence of tonic nM DA, and LP activity phase is restored (Rodgers, Fu et al. 2011, Krenz, 
Hooper et al. 2013, Krenz, Rodgers et al. 2015). Tonic DA mediates LP phase recovery by 
permitting activity-dependent regulation of Ih that restored the correlation between LP IA and Ih 
(Krenz, Rodgers et al. 2015). The work that was presented in this study further illuminated the 
mechanism through which tonic DA acts to stabilize activity. Tonic DA can select the ionic 
conductance target for activity-dependent regulation by SUMO. 
In addition to regulating ionic conductances to maintain a stable rhythmically active 
network, studies using rodent models have also described a role for tonic DA in the regulation of 
synaptic plasticity. Recent behavioral research in mice has shown that tonic DA is important for 
preserving and maintaining a learned association (Ellwood, Patel et al. 2017). In this study, 
optogenetic stimulation was used to drive either tonic or phasic firing of DA neurons while 
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examining the function of each in a task that requires the mice to learn a specific association and 
then switch to a new association. The researchers found that phasic DA mediated the learning of 
new associations while tonic DA preserved the previously learned association, hindering the 
learning of a new one (Ellwood, Patel et al. 2017). While this behavior based study does not yet 
speak to a specific mechanism, it highlights the importance of tonic DA maintaining a learned 
plasticity state. Research in the rat prefrontal cortex has found that tonic DA is needed for the 
appropriate induction of LTP. In the presence of “normal” physiological levels of tonic DA, 
high-frequency stimulation induces LTP (Matsuda, Marzo et al. 2006). However, through the use 
of either DA agonist/antagonist or PFC slice cultures that are absent of dopaminergic tone, 
researchers have discovered phasic DA can trigger either LTD or LTP in the prefrontal cortex 
depending on the level of dopaminergic tone (Otani, Bai et al. 2015). Phasic DA stimulation in 
the presence of low/no or elevated tonic DA induces LTD (Otani, Blond et al. 1998, Otani, 
Auclair et al. 1999); conversely, phasic DA stimulation in the presence of physiological levels of 
tonic DA induces LTP (Matsuda, Marzo et al. 2006). Taken together, these studies illustrate 
diverse roles for tonic DA that may vary based on cell type and cellular context.  
5.2.3 Dysfunctions associated with dopaminergic tone 
Understanding disease states that are associated with alterations in dopaminergic tone can 
provide valuable insight into its behavioral and physiological functions. This is not always an 
easy task, however, because many dysfunctions that result from alterations in the DA system 
may affect both tonic and phasic DA. Yet, researchers are making efforts to distinguish between 
the two, because understanding whether certain symptoms result from alterations in 
dopaminergic tone versus phasic DA release can better inform what treatments may be most 
effective. For example, in Parkinson’s Disease, a majority of the symptoms associated with the 
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disease (resting tremors, rigidity, and bradykinesia) result from the loss of dopaminergic neurons 
in the substantia nigra (Hammond, Bergman et al. 2007). This would mean that dopaminergic 
tone would be significantly depleted. Researchers have linked this decrease in tonic DA to a 
significant down-regulation in HCN channel expression in globus pallidus neurons, leading to 
the motor dysfunction associated with Parkinson’s Disease (Chan, Glajch et al. 2011). These 
findings are particularly relevant to the work presented here because we have also shown that 
tonic DA plays a significant role in both short-term and long-term regulation of Ih (Rodgers, Fu 
et al. 2011, Krenz, Hooper et al. 2013, Krenz, Parker et al. 2014, Krenz, Rodgers et al. 2015).  
Disruption in tonic DA has also been suggested to play an important role in Attention 
Deficit Hyperactivity Disorder (ADHD). Recent studies have shown that in human subjects 
diagnosed with ADHD tonic DA in the right caudate was significantly reduced, whereas phasic 
DA release in the right caudate was significantly increased (Sikstrom and Soderlund 2007, 
Badgaiyan, Sinha et al. 2015). These results are consistent with the attentional deficits associated 
with ADHD because the right caudate is known to control executive inhibition and selective 
attention, and dysfunctional regulation of this region could lead to attentional deficits. Substance 
addiction is also correlated to alterations in tonic DA. Specifically, it has been shown that 
repeated drug administration increases tonic DA, consequently decreasing the phasic response 
(Grace 2000). This subdued phasic response would increase drug-seeking behavior because 
stronger doses would be needed to elicit the desired phasic response, further increasing the 
dopaminergic tone in a vicious cycle. Lastly, Schizophrenia is associated with hyper-
responsiveness of the dopaminergic system (Grace 1991, Durstewitz and Seamans 2008, Grace 
2016). The evidence indicates that this hyperdopaminergic state results from hyperactivity of the 
hippocampus, which supplies excitatory afferent stimulation to VTA dopaminergic neurons 
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(Heckers 2001, Medoff, Holcomb et al. 2001, Grace 2016). This leads to an increase in tonically 
active DA neurons and thereby an enhanced phasic response. It is clear that dysregulation of the 
dopamine system has far reaching implication, and it has become more apparent over time that to 
fully understand these disease states we must examine the distinct role of both tonic and phasic 
DA and how the two intersect. 
5.3 Limitations of Exogenous Expression and Heterologous Expression Systems 
With any form of research, it is important to understand the limitations of your chosen 
system and experimental techniques. A significant portion of the research presented here utilizes 
Hek cells as a heterologous expression system to stably express the HCN channel, which can 
then be used to study the effects of SUMOylation on the channel. Hek cells are widely used for 
studies investigating protein-protein interactions because they divide quickly and are easily 
transfected and cultured in a laboratory setting. However, stable expression of a protein requires 
the gene for the new protein be integrated into the Hek cell genome, and there is no way to 
control the number of copies that have been integrated into the genome. This means that when 
comparing across separate stable cell lines, for example, cell lines expressing the wild-type 
protein versus a mutated form of the protein, each cell line could have a different copy number. 
In our study, we look at SUMO modification of HCN channels stably expressed in Hek cells. 
Therefore, if a particular cell line expresses the channel at a significantly higher level, the 
endogenous SUMOylation machinery may not be able to maintain the baseline (control) level of 
SUMOylated HCN channels at a level that is consistent with the other cells lines with lower 
HCN channel expression. These types of differences are important to consider when interpreting 
your findings using a heterologous expression system.  
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Researchers also commonly use exogenous expression of a protein or gene of interest to 
study its effects. For example, in our study we transfected SUMO and Ubc9 to overexpress those 
proteins in Hek cells. We also used Tat-SUMO to exogenously increase SUMOylation in the 
STG neurons. Four our research, these techniques provide valuable information about the effects 
SUMOylation on a specific channel or ionic current, but these findings should also be considered 
in a biological context. Is increasing SUMOylation to the maximum level that the endogenous 
enzymes can accommodate producing a change that could be observed under normal biological 
conditions? For this reason, it is important also to consider including experiments that examine 
changes that occur through endogenous mechanisms and then the effect of the response to 
exogenous expression can be compared to the endogenous response. 
5.4 Conclusions 
This dissertation has provided evidence of a novel regulatory role for SUMOylation in 
the coregulation of IA and Ih. This finding is significant because, conductance correlations play 
an important part in neuronal homeostasis, and this study can further illuminate the mechanisms 
that mediate rapid homeostatic coregulation of ionic conductances because they are as of yet not 
well understood. This work has also demonstrated a mechanism by which tonic DA can select 
ionic conductance targets for activity-dependent regulation by SUMO. This is an important 
finding because researchers are only just beginning to investigate the specific mechanisms that 
underlie tonic DA regulation of neural network activity. Until now there has been no evidence 
that modulatory tone is involved in SUMO regulation of ionic conductances. Therefore, this 
study has provided a new line of investigation that can have far-reaching implication in the study 
of neuronal homeostasis, tonic DA regulation of neuronal activity, and SUMO regulation of 
ionic conductances in vertebrates as well as invertebrates.  
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